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Abstract
Cancer incidence is high for aging minority and underserved populations, yet research is
limited about patient-provider communications with aging racial and ethnic minority
populations. Achieving high-quality cancer care is crucial to reducing health disparities
for this population. However, potential shortages in professional health personnel, the
cost to treat cancer, a strained health care system, and large aging populations contribute
to the problem. The purpose of this qualitative study was to understand the personal
experiences of aging minorities during cancer treatment decision making when
communicating with their cancer care providers. Purposive sampling methods used to
recruit 10 minority women and men born between 1946 and 1964 who had experienced
communicating with providers and making cancer treatment decisions. In-depth semistructured interviews and thematic analysis of qualitative data was conducted. Important
findings were barriers related to miscommunication with providers, the need for more
time with the cancer doctor, and mistrust of the medical profession. Participants
perceived poor interpersonal communication with providers as causing a lack of
understanding regarding their cancer treatment options, which affected their decision
making regarding their treatment. Barriers to communication included long wait times at
public or teaching health care systems for follow up cancer care services. The findings of
this study could be useful to assist health care providers in improving communication
with their cancer patients, reducing cancer health disparities, and increasing the quality of
cancer care for this population.
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Chapter 1: Introduction to the Study
Introduction
Treatment decision-making with cancer is critical to successful care, mainly
through effective patient-provider communications where information that is provided to
the patient’s satisfaction. It is essential that providers communicate information about the
patients’ specific cancer diagnosis, expected outlook, options available to treat the
disease, and potential side effects, in order to succeed in providing quality care
(Sheppard, Adams, Lamdan, & Taylor, 2010). In the study I used a qualitative approach
to investigate phenomena related to patient-provider communication with aging Baby
Boomer minorities and investigated how communication influences clinical decisionmaking.
Public health practitioners and policymakers are important in promoting healthy
aging (Centers for Disease Control and Prevention [CDC], 2013). Cancer is a public
health matter (CDC, 2013); public health can meet the developing needs of an aging
society (Holtzman & Anderson, 2012). The incidence of cancer projected to increase
among racial and ethnic minorities in the coming years (Edwards et al., 2014; Rahib et
al., 2014). Moreover, by 2030, one in every five Americans—about 72 million people—
will be over the age of 65. Statistics indicate the cumulative projected incidence of cancer
will escalate by 45%, from 1.6 million to 2.3 million (Smith, Smith, Hurria, Hortobagyl,
& Buckholz, 2009). The site-specific cancers that primarily affect older adults and
minorities in 2030 will be breast, colorectal, lung, and prostate. Estimating projections for
incidence and mortality cancer rates can change due to prevention, advances in treatment
1
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and changing demographics (Smith et al., 2009). Cancer rates for many sites are also
expected to rise among minorities and older adults by 2030 (Tables 1 and 2), from 21%
to 28% (Smith et al., 2009; Figure 1).

Table 1
Projected Cancer Patients by Age and Sex from 2010 Through 2030
All

Cancer Site
and Year

Age 65+

No.

%

No.

2010

1,599,000

—

967,000

2020

1,957,000

2030

2,318,000

Women
%

No.

Men
%

No.

%

— 761,000

—

838,000

—

22 1,302,000

35 900,000

18 1,057,000

26

45 1,618,000

67 1,049,000

38 1,269,000

51

All

Table 2
Projected Cancer Patients by Racial Ethnicity from 2010 Through 2030

Cancer Site
and Year

White

No.

Asian and
American Indian
Multiracial
Pacific Islander and Alaska Native

Black

%

No.

%

No.

%

No.

%

Hispanic

No.

%

No.

%

1,268,000 — 165,000 — 41,000

—

6,000

—

12,000 — 107,000 —

1,480,000 17 217,000 31 64,000

58

8,000

39

18,000 45 171,000 59

1,658,000 31 272,000 64 94,000

132

10,000

76

24,000 101 260,000 142

All
2010
2020
2030

Source: Smith, Smith, Hurria, Hortobagyl, & Buckholz, 2009
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Figure 1. Cancer projections by race and origin in the United States by 2030.

Despite the continued growth of aging populations in the United States, research
shows limited information exploring aging minorities involved in their own cancer care
(Sysmonds, Lord, Mitchell, & Raghaven, 2012). Improving quality outcomes could
influence cancer health disparities as this racially and ethnically diverse population ages
(Nathan, Marshall, Cooper, & Huang, 2016). The incidence of cancer for older minorities
presents multiple challenges. For example, cancer and treatments can be affected by age,
race or ethnicity, genetic and biological influences, and physician and patient discussions.
3
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Barriers to cancer treatment in older minorities include poverty, access to transportation,
illiteracy, mental health, disabilities, cultural influences, access to quality cancer care,
and poor language communications (U.S. Health and Human Services, Office of Disease
Prevention and Health Promotion, 2014).
This qualitative phenomenological research directly observed cancer treatment
decision-making experiences among minorities born between 1946 and 1964—post
World War II individuals. Quality cancer treatment includes patients and families
educating themselves about treatment decisions and selecting effective treatment options
that could reduce the growth of cancer while maintaining the quality of life during the
cancer treatment process (American Cancer Society [ACS], 2016; Institute of Medicine
[IOM], 2013). Additionally, a disproportionate number of African American, Asian,
Hispanic or Latino, and American Indian/Alaska Native persons are likely to suffer a
greater disease burden. Understanding patient-provider communication, a review of the
role and impact of culture and socioeconomic status on cancer health disparities is
significant.
Background of the Study Problem
Cancer is a leading cause of death of all ethnicities among both men and women
(CDC, 2015). Screening can prevent many types of cancer including breast, colon,
cervix, lung, or prostate and early detection may mean less intrusive treatment and better
patient outcomes. Individuals who smoke, have poor diets, engage in limited physical
activity, have a family history of the disease, and are exposed to certain environmental
risk factors are at high risk for cancer (ACS, 2015). Cancer statistics show that over 1.6
4
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million individuals were projected to be diagnosed with cancer in 2017 (ACS, 2016), and
the incidence of cancer was highest for the aged, minorities, and underserved populations
(CDC, 2011; O’Keefe, Meltzer, & Bethea, 2015). ACS data for 2016 found that 595,690
people died from cancer that year (ACS, 2016). Approximately 86% of individuals over
50 years old are at risk for cancer (ACS, 2016).
The first wave of Baby Boomer Americans turned 65 in 2011, and 10,000
Americans celebrate their 65th birthdays each day (Pew Research Center, 2010).
Consequently, cancer cases anticipate growing among this specific population of older
Americans (White et al., 2014; ACS, 2016). The last wave of the Baby Boomer
population (those born in the 1960s) will be 65 in the year 2029. This increase in the
aging population in the United States will have wide impact on public health, social
services, and healthcare. It will be important to promote healthy aging (CDC, 2013).
Addressing cancer health disparities among aging minorities is critical to the
health objectives for the United States through the Healthy People 2020 program (U.S.
Department of Health and Human Services, Office of Disease Prevention and Health
Promotion, 2014). Overarching goals of Healthy People 2020 are to achieve high quality
health care, eliminate health disparities, and advance the health of all groups in the
United States (U.S. Department of Health and Human Services, Office of Disease
Prevention and Health Promotion, 2014). Efforts to reduce cancer health disparities
require effective patient-provider communication strategies (Smedley, Stith, & Nelson,
2003). However, ineffective patient-provider communication strategies for cancer
treatment for minority and underserved populations may result in negative cancer care
5
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treatment and outcomes (Sheppard et al., 2011). Several benefits of effective patientprovider communications strategies for cancer treatment are provision of information to
help patient decision-making with cancer care and good communication to strengthen
patients’ social support networks, reduce anxiety, deliver high-quality cancer care, and
improve quality of life (Mead et al., 2013; Wilkins et al., 2012). Numerous studies
confirm the importance of effective patient-provider communications for initial cancer
treatments, which result in improved survival outcomes (Epstein & Street, 2007; Palmer
et al., 2014).
Although morbidity and mortality of cancer have decreased and technological
advances in cancer treatment have increased, minority populations experience lower
cancer survival outcomes (IOM, 2013; Zonderman, Ejiogu, Norbeck, & Evans, 2013).
Medically underserved racial and ethnic groups often present with a greater cancer
burden, resulting in late stage diagnosis and poor survival outcomes, as compared to
Whites (Byrd et al., 2011; Thompson et al., 2013). Moreover, medical providers who
may be limited in their efforts to communicate to aging ethnic minorities (Schwartz,
Lowe, & Sinclair) compound poor cancer outcomes. These populations are often low
socioeconomic status, un- or underinsured, with limited health care access and
underrepresentation in clinical trials, all of which create delays in receipt of cancer
treatments in minority populations (IOM, 2013). Aging African American, Asian,
Hispanic or Latino, and American Indian/Alaska Native populations disproportionately
suffer a greater cancer burden (National Cancer Institute [NCI], 2015). According to the
U.S. Census, between 2016 and 2030, White (not Hispanic) population age 65 and over is
6
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expected to increase by 39% compared to 89% for older racial and ethnic minority
populations (U.S. Census Bureau, 2017).

Expected Population Growth 65 and over
Ethnic Minoritites, 2016-2030

African Americans
(73%)

American Indian
Native Alaskans
(72%)

Asians (81%)

Hispanics (112%)

Figure 2. Expected population growth 65 and over, ethnic minorities, and 2016-2030.
Source: U.S. Census Bureau. (2017). Population Division, Annual Estimates of
the Resident Population by Sex, Age, Race, and Hispanic Origin for the United States
and States: April 1, 2010 to July 1, 2016.

Problem Statement
There is limited research concerning the impact of patient-provider
communications and cancer treatment decision-making options among aging racial-ethnic
minorities who may have multiple communications challenges. Provider understanding of
diverse cultural norms along with low health literacy of patients may affect access to
cancer care (Epstien & Street, 2007; Sheppard et al., 2010). Cancer treatment options
include surgery, radiation therapy, chemotherapy, hormone therapy, and immune therapy,
all of which depend upon the type and size of cancer and whether cancer has spread to
other parts in the body (ACS, 2015; NCI, 2015). From diagnosis to the sophisticated
7
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treatment options available, several things influence cancer treatment. First is the
financial burden many families experience. Another is patients’ limited experience with
healthcare systems, and a third is understanding cancer care and treatment information in
decision-making. Furthermore, structural barriers that include inadequate health
insurance, the complexity of the health care system, the treatment facility operating
hours, wait times to receive treatment, and access to transportation (ACS, 2016) impact
cancer treatment. Patient-provider communication also affects specific cancer treatment
delivery (ACS, 2016). Lastly, the clinician can also contribute to poor patient-provider
communication and poor prognosis due to lack of training and insensitivity to patients’
cultural backgrounds and the psychosocial, sexual, and emotional issues experienced by
cancer patients (Epstein and Street, 2007).
According to the IOM (2013), quality cancer care happens when patients and
families are the center of information exchange so they can make informed cancer
treatment decisions. Effective patient-centered communications in cancer include open
communications between cancer patients and the clinical team using evidence-based
research to: (a) inform everyone about treatment options, (b) share decision making to
influence patient outcomes, and (c) more fully involve patients with their care (Gagliardi
et al., 2014; IOM, 2013; Epstein & Street, 2007). Shared control versus a physician
control partnership is interrelated to the cancer patient’s level of education, ethnicity,
gender, and participation in the cancer encounter (U.S. Department of Health and Human
Services, National Institutes of Health [NIH], 2015]). Poor healthcare literacy in older
adults impact a cancer patient’s ability to communicate with physicians or clinical staff
8
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about chronic diseases (IOM, 2011). Inadequate healthcare literacy can also lead to high
mortality due to poor health status (CDC, 2016).
The incidence of cancer is highest for aging minority and underserved populations
(CDC, 2013). Racial and ethnic minority patients have multiple barriers to cancer
treatment including access to care, culture, language, and low health literacy
understanding about cancer diagnosis (Ko, Zuniga, Peacher, Palomino, & Watson, 2016).
Some studies suggest that culture, issues of trust, poor healthcare literacy, or limited
understanding of cancer prevention and control information may affect communication
inequities (Palmer et al., 2014).
Studies have documented recommendations to improve cancer communications
for racial and ethnic minorities require practitioners to be culturally competent and
effectively deliver information for decision-making about cancer treatment (Surbon 2010;
Moore & Spiegel, 2004). Several studies show persistent challenges and disparities in
clinical and patient communication and decision-making for cancer treatment among
ethnic minority groups (Ko, et al., 2016; Palmer et al., 2014). In a systematic review of
medical communications with racial-ethnic minorities, Ko et al. (2016) identified gaps in
the effectiveness of clinician-patient communication among racial ethnicities. Other
studies showed that physicians provided more limited health information to ethnic
minority patients than to non-Hispanic White patients (U.S. Agency for Healthcare
Research and Quality [AHRQ], 2015). In similar study, researchers examined racial and
ethnic disparities in patient-provider communication and follow-up cancer care among
older cancer survivors. Researchers concluded that Asians survivors perceived the worst
9
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follow-up cancer care with providers on quality care ratings as compared to Whites
(Palmer et al., 2014). In this research study, I explored an important gap in understanding
what patient-provider communication characteristics influence health outcomes of cancer
patients, particularly how they affect cancer treatment decision-making for aging racial
and ethnic minorities. Understanding the impact of these influences on cancer is critical
to providing high quality cancer care for racial ethnic populations and reducing health
disparities (NCI, 2017; CDC, 2013).
Purpose of the Study
The purpose of the study was to understand the personal decision-making
experiences of aging minorities during cancer treatment when communicating with their
cancer care providers. While there are studies that examine the cancer treatment
experiences of non-Hispanic White men and women, there is limited understanding of the
experiences of Baby Boomer minorities undergoing cancer treatment and care. This study
focused on cancer treatment decision-making and patient-provider communication from
the perspectives of minorities born between 1946 and 1964. This population often has
less access to quality cancer care and may have fewer options to participate in cancer care
decision-making (ACS, 2014). Information that does not effectively address the needs of
Baby Boomer minority patients is a major concern in cancer treatment for this
population. Understanding how this population perceives their own cancer diagnosis and
treatment options is critical in reducing mortality and increasing cancer survival rates.
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Research Questions
The research questions guided the in-depth interviews, which was the primary
collection tool to identify cancer treatment decision-making processes based on patientprovider communication of African American, Asian, Hispanic or Latino, and American
Indian/Alaska Native patients. The following research questions informed the study:
Research Question 1: Do inadequate time allowed for medical decision-making
and lack of active listening and empathy by care providers prove to be barriers to
patient-provider communication for Baby Boomer minorities?
Research Question 2: What are facilitators for post-cancer treatment (e.g., access
to quality care and supportive networks) that improve quality of life of Baby
Boomer minority cancer survivors? What are the barriers to improved quality of
life?
Understanding the differences between barriers and facilitators in cancer treatment
decision-making and the types of treatments received by Baby Boomer minorities could
help identify appropriate interventions for improving patient-provider cancer
communication and reduce cancer disparities among aging minorities.
Conceptual Framework
The conceptual framework for this research was the social-ecological model
(SEM). Public health officials for interventions at various levels to influence specific
cancer care behaviors have used the SEM. The SEM was created by Bronfenbrenner
(1979) and expanded by McLeroy, Bilbeau, Steckler, and Glanz (1988) to further the
understanding of relationships between individual- and population-based determinants of
11
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behavioral health from an ecological perspective (Moore, Buchanan, Fairley, & Smith,
2015). The SEM framework identifies factors that influence behavior at multiple levels of
an intervention designed to implement or encourage change at individual, interpersonal,
organizational, community, and policy levels (McLeroy et al., 1988). Thus, the SEM
framework’s multiple levels of influence used to improve health systems for cancer
patients and reduce health disparities of minority aging populations through public health
policies and programs (Moore et al., 2015). For example, activities at the community
level of the SEM can facilitate comprehensive cancer control coalitions implement
activities to support cancer survivorship among aging minorities have access to quality
cancer care.
Nature of the Study
This was a qualitative research study. A phenomenological study was the most
appropriate methodology to examine the beliefs and influences that guide aging
minorities’ experiences with cancer treatment decision-making and communicating with
their providers. Phenomenological studies focus on lived experiences or events in
people’s lives that can better understand their perspectives and how they see their world
(Husserl, 1970). Timely and accurate communication better informs decision-making
critical to helping cancer patients navigate the myriad challenges present in a healthcare
system in order to receive effective cancer treatment. The aim of this study was to outline
improvements in patient-provider communication and provide insights into health care
system changes that could improve cancer treatment outcomes. For this study, 10 men
and women participant who are cancer survivors currently undergoing cancer treatment
12
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and were asked about their cancer treatment experiences. The data collection method was
semi-structured interviews and observation of the participants to understand cultural
nuances. In this research, I sought to determine effective interventions designed to
eliminate or reduce cancer health disparities for aging minorities and to increase their
quality of care for improved health outcomes.
Definitions of Terms
I used the following terms in developing an understanding of cancer treatment
decision-making among minorities born between 1946 and 1964:
Cancer: A group of abnormal cells that divide into multiple cells and can invade
healthy tissues (CDC, 2016).
Cancer staging: The extent of the cancer, such as the size of a tumor and if the
tumor has metastasized in the body (NCI, 2015).
Cancer survivor: A person diagnosed with cancer and still living with the disease
(CDC, 2016).
Cancer treatment: Treatment for cancer patients. Cancer treatment plans include
surgery, radiation therapy, and chemotherapy (CDC, 2016).
Decision-making or shared decision-making: Collaborative activities that
encourage health care professionals and patients to make medical decisions together as an
approach to improving the provider-patient communication process (NCI, 2015).
Health equity: The social and medical determinants of access to health care for
individuals to attain positive health outcomes (Braveman et al., 2011; U.S. Health and
Human Services, Office of Disease Prevention and Health Promotion, 2014).
13
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Health disparities or inequalities: are adverse differences in health status among
populations; unfair healthcare (justice) systematically linked among socially
disadvantaged populations with poor health (Braveman et al., 2011; NCI, 2015; U.S.
Health and Human Services, Office of Disease Prevention and Health Promotion, 2014).
Patient-centered care: A type of care that promotes effective communication
between patients and their families and clinicians and health systems, to engage patients
as active participants in their care to improve health care outcomes and increase patient
satisfaction. (Epstein and Street, 2012).
Patient-provider communication: Effective interpersonal communication
between patients and health care providers to improve health outcomes and adherence to
treatment recommendations (Epstein and Street, 2007; Sheldon, Haoung, Berry, 2011).
Quality of life: A person’s overall sense of well-being and ability to complete a
variety of activities following cancer treatment (NIH, 2016).
Social determinants of health: A complex web of the physical environment,
health services, and societal factors that shape the conditions in which individuals live
that promote health and avoid health inequalities (U.S. Health and Human Services,
Office of Disease Prevention and Health Promotion, 2014; Stewart & Wild, 2016).
Assumptions
The assumptions of this study were that participants’ goals were quality, healthy
cancer treatment outcomes as long-term cancer survivors. I explained the questions to the
participants to help ensure accurate data collection, and the participants conveyed their
experiences of cancer treatment decision-making by responding appropriately to the
14
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questionnaire. I also assumed the participants had a previous cancer screening or waited
until late stage after receiving a diagnosis of cancer. I assumed the participants’ interacted
with their cancer providers’ communication style.
Scope and Delimitations
This study examined themes of experiences by Baby Boomer minorities and their
perceptions of cancer care treatment for older adults. These themes included shared
decision-making, communication with and trust of the cancer care provider, and the level
of satisfaction with cancer treatment. I did not observe interaction with clinicians but
discussed with participants’ their previous cancer treatment decision-making experiences.
Aging is a risk factor for cancer, and this study focused on midlife minority men and
women between 54 to 72 years old. The participants of this study have had limited access
to cancer care were low SES aging minorities. The results of the study may not be
generalizable to a larger population.
Limitations to the Study
This qualitative study was limited to a small sample size of Baby Boomer
minorities living in Atlanta, Georgia. The study was limited to patients living with any
form of cancer. Either persons living with cancer or those diagnosed with cancer at some
point throughout their lifetimes. A potential bias was limited to the selection of
participants who are only a sample of the population they represent. The results from this
small sample size may not be generalizable. Measures were taken to ensure the accuracy
and confidentially of participant data in the analysis.
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Significance of the Study
This study, conducted with aging Baby Boomer minorities from Atlanta, Georgia,
contributes to the body of knowledge regarding patient-provider communication
experiences and the subsequent influences of those communications on cancer treatment
decision-making. The findings might prompt additional research to discover effective
interventions to improve patient-provider communication and eliminate cancer health
disparities for the targeted population. The implications of this knowledge are that it
could have the potential to promote a positive social change through cancer care
providers who assist aging minority cancer survivors to have a better quality of life while
receiving cancer treatment. The cancer study can potentially replicate to other public
health interventions to increase population-based cancer screening and control efforts.
Implications for Social Change
There are several implications for positive social change resulting from this
research. Among them are informing public health organizations about cancer health
disparities among aging racial and ethnic groups in the United States. While cancer
mortality rates have decreased in general population studies, cancer incidence remains
high among certain racial and ethnic minorities (Halpern, 2015; National Cancer Institute
[NCI, 2015]; Ramirez, 2013). Positive social change implications of this study may be
improvements in access to cancer treatment and better patient-provider communication;
another may be to provide insights into health systems changes needed to improve cancer
outcomes and reduce health disparities for racial and ethnic minorities. A final social
change implication could be to advance the quality of life among aging minority
16
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individuals by improving the experiences of cancer survivors through public health
programs and policies.
Summary
In conclusion, despite access to cancer screening and technological advances in
cancer care and treatment, more progress is necessary to reduce new cancer cases and
increase quality cancer care for aging racial and ethnic minorities. In this
phenomenological study, I sought to identify patient experiences and the provider
behavioral influences that affect patient-provider communication and contribute to cancer
health disparities among Baby Boomer minorities. The study was an examination of this
population’s beliefs, perceptions, and experiences when discussing provider
communications about cancer diagnosis and treatment.
In Chapter 2, I address relevant literature on cancer treatment decision-making
that supports the need for the study. In Chapter 3 expanded, I address the methodology
used for data collection and answer research questions. Chapter 4, presents research
findings from the in-depth interviews of study participants, and in Chapter 5, I interpret
the results and make recommendations for the research needs of the population under
study.
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Chapter 2: Literature Review
Introduction
In this study, I examined the relationship between patient-provider
communications among minority Baby Boomer individuals’ cancer treatment decisionmaking. A substantial number of studies identify the importance of patient and provider
interactions for positive clinical outcomes; however, much of the current literature relates
only to health disparities. The review for this study was limited to literature on aging and
cancer health disparities faced by underserved aging minority populations regarding
cancer treatment and patient outcomes.
Literature searches identified related qualitative studies on cancer epidemiology,
health disparities and health equity, differences in cancer incidence among Baby Boomer
minorities, and patient-provider communication about cancer treatment in aging minority
populations. My research inquiries sought peer-review literature, public health reviews,
and books. The databases searched included MEDLINE and Psych Info. Keywords and
phrases used for the search were cancer health disparities, inequalities, racism, gender,
race, ethnicity, underserved, patient satisfaction, patient-provider communication,
patient navigation, race concordance, and aging minorities. The articles selected for this
review explored topics on cancer health disparities and research on aging minority
populations. I analyzed the studies published between 2007 and 2017 in this review using
a literature matrix to examine the research questions, methodologies, and research
designs, samples, analyses, and recommendations for future cancer studies.

18
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Conceptual Framework
There have been few studies specifically on aging racial and ethnic minorities and
their cancer care decision making. The SEM was the framework used to guide this study;
it helped me explain the interrelationship between aging minorities and cancer providers
and to articulate the importance of effective communication with multiple levels of
influences on cancer prevention and control.
The SEM primarily focuses on the individual and population levels that determine
health behavior at intrapersonal, interpersonal, organizational, community, and public
policy levels (Moore et al., 2015; Fielding, Teutsch, & Breslow, 2010; McLeroy et al.,
1988). These levels of the SEM describing health behavior are all interdependent
(McLeroy et al., 1988):


The intrapersonal level or individual behavior refers to knowledge, attitudes,
personal and demographic characteristics that influence health behavior
(McLeroy et al., 1988).



The interpersonal level is social support systems of family, friends, coworkers, and others persons that can influence health behavior (McLeroy et
al., 1988).



The organizational level refers to institutions in organizational settings such as
a school or workplace that plays a significant role in health behavior
(McLeroy et al., 1988).
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The community level speaks to relationships among groups, institutions,
organizational structures, and neighborhoods that impact access to care and
influence health behavior (McLeroy et al., 1988).



The policy level concerns public policies from local, state, national
governmental agencies that affect health behavior (McLeroy et al., 1988).

In an earlier study, Earp, Altpeter, Mayne, Viadro, and O’Malley (1995) designed
an intervention to direct minority, rural women 50 years and older to mammography
screening in a five-county region of North Carolina. The researchers used various
theoretical constructs of the social ecological model; PRECEDE model for health
promotion, the Health Belief Model and the Stages of Change model for behavior change
to increase breast cancer screening in older minority women. The social change
implication was to reduce cancer mortality among racial ethnic populations. Studies have
suggested that low-income African American are more likely to die of breast cancer as
compared to White women (Hall & Johnson-Turbes, 2015).
McNeill et al. (2009) developed an intervention based on the social ecological
framework that examined health behavior through a randomized controlled trial to
increase colorectal cancer screening among low-income racial and ethnic minority adults
over 50 years of age in public housing units. The researchers examined social support and
social networks in public housing residents and trained peer health advisors to increased
rates for colorectal cancer screening among residents. The study examined 12 housing
sites to determine if residents received a recommendation for colorectal cancer screening,
health insurance status, and other health related outcomes.
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The public health action model for cancer survivorship developed by Moore et al.
(2015) was an integrated model of the SEM. This framework was significant in
addressing the public health needs of cancer survivors through the National Action Plan
for Cancer Survivorship (Moore et al., 2015). This integrated SEM model includes a
collaboration of intrapersonal and interpersonal networks, community and organizational
groups, and policies (Moore et al., 2015; Figure 3).

Figure 3. Diagram of SEM an integrated framework. Source: Adopted from Moore et al.,
2015
Health Disparities and Health Equity
Health disparities defined by multiple entities and often used in the literature to
describe inequality in utilization of health care services. An IOM (2013) report describes
health disparities as "differences in access to available health care" (p. 29). In 2000,
Congress passed Public Law 106-525 known as the Minority Health and Health
Disparities Research and Education Act of 2000 (NCI, 2016). The law authorized the
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NCI to establish the National Institute for Minority Health and Health Disparities to
improve health lives of minorities (NCI, 2016). The NCI defines health disparities as
follows: "A population is a health disparity population if there is a significant disparity in
the overall rate of disease incidence, prevalence, morbidity, mortality or survival rates in
the population as compared to the health status of the general population" (Minority
Health and Health Disparities Research and Education Act of 2000, p. 2498).
Several factors determine health disparities (CDC, 2013). One is socioeconomic
status, which influences a person’s position in society. Socioeconomic status may be
determined by income, educational attainment, occupation, health care access, and
financial wealth (Saydah, Impertore, & Beckles, 2013; CDC, 2013). According to CDC’s
Health Disparities and Inequalities Report, researchers concluded that higher education
and incomes contribute to better access to health care (CDC, 2013). The same report
found that having only a high school diploma along with living in poverty negatively
affects health outcomes. The CDC report described disparities with multiple diseases,
risk factors, environmental assessments, social determinants, and access to health care
(CDC, 2013). Barriers to cancer treatment and accessing health care services are critical
for underserved and geographically confined ethnic minority populations (NCI, 2015).
Other factors that complicate poor cancer outcomes include higher levels of
environmental carcinogens, risk factors such as cigarette smoking and poor diet, and lack
of health education about health risks (CDC, 2013, IOM, 2013, NCI, 2015). Studies show
that some people with low socioeconomic status are at a higher risk of disease due to
environmental exposures (CDC, 2013, O’Keefe et al., 2015). Individuals of low
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socioeconomic status also have limited access to nutritious foods that may lower cancer
risk (O'Keefe et al., 2015).
In addition to socioeconomic status, other social determinants cause health
disparities. These include where a person is born and raised, where they work, and their
age; also, the delivery of health care (CDC, 2013). According to the World Health
Organization (Stewart & Wild, 2016), "the social determinants of health are mostly
responsible for health inequities—the unfair and avoidable differences in health status
seen within and between countries" (p. 6). Additional social determinants of health
include race and ethnicity, sex, sexual orientation, age, and disability (CDC, 2014). Data
from CDC's Reaching Ethnic Approaches to Community Health obtained from
surveillance of several U.S. communities showed racial and ethnic communities have a
high burden of disease and limited access to health care services in comparison among
the majority populations in the same area (CDC, 2014).
Disparities of Cancer Incidence in Baby Boomers Minorities
Many governmental and non-governmental agencies track cancer incidence of all
populations and minority populations. Data from the ACS estimate that around 1,685,210
new reports of cancer diagnosis projected in 2016 and 1,630 people will die each day
from cancer in 2016 (ACS, 2016). The National Cancer Institute (NCI) Surveillance,
Epidemiology, and End Results (SEER) project new cases reported as 448.7 per 100,000
individuals annually (NCI, 2016). Mortality data show 168.5 per 100,000 individuals
annually was based age-adjusted 2009-2013 cases and fatalities (NCI, 2015). In 2013, an
estimated 14,140,254 people living with cancer in the United States among all cancer
23

24
(NCI, 2015) one out of every 25 Americans is a cancer survivor (ACS, 2014). The
potential for cancer increases with advancing age (CDC, 2013); with 86 percent of
cancers diagnosed are those individuals over 50 years old in the United States (ACS,
2016).
Although there continues to show notable gains overall health of Americans
(Healthy People 2020), disparities in the morbidity and mortality specifically among
African Americans, Hispanics, Native Americans, Alaska Natives, and Asian Pacific
Islanders remains a serious health threat (CDC, 2015). The NCI defines cancer health
disparities as “adverse differences in cancer incidence, prevalence, and mortality” (NCI,
2015). Disparities also exist due to geography or region of the country. The elderly,
disabled people, and uninsured populations in the study population often reside in rural
places where shortages of medically qualified personnel. In addition, seniors in these
rural areas—who live below the poverty line, must often travel long distances to seek
medical care (CDC, 2015).
There is also a continuing increase of minority populations with cancer in the
United States (NCI, 2015). Data from the Administration on Aging (AoA) indicate aging
adults of color have expanded an additional 3.2 million between 2003 to 9.5 million in
2013 (AoA, 2013). The older population estimated growth is around 21.1 million in 2030
(AoA, 2013). The aging white population is forecasted a 50 percent increase from 2013
to 2030 for those individuals over 65 in comparison to 123 percent for aging adults of
color (AoA, 2014). The changing demographics of racial and ethnic minorities aging
statistics are the results of the aging Baby Boomers cohort.
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The Baby Boomers Cohort
According to U.S census data, the Baby Boomers cohort (U.S. Census Bureau,
2014) has drastically altered populations. Therefore, it is important to understanding this
group and it will shape the demographic composition of the United in the future. This
birth cohort is responsible for the significant rise in birth rates between 1946 and 1964
(U.S. Census, 2014). This generation has influenced many sectors such housing,
recreation, business, healthcare, education, and government as they move into retirement
and old age (AoA, 2013). The first year the Baby Boomers generations turned 65 was in
2011. By 2029, this generation will make up over 20 percent among the U.S. population
(AoA, 2013; U.S. Census, 2014). Within this cohort is more racially and ethnically
diverse and is expected to grow into a majority population by 2043 (AoA, 2013; U.S.
Census, 2014).
Race and Ethnic Composition of Baby Boomers Minorities
The composition of minorities represents a range of races and ethnicities where
21.2 percent of those age 65 and over: 8.6 percent were African-Americans; 3.9 percent
were Asian or Pacific Islander; 0.5 percent were Native American;; 0.1 percent were
Native Hawaiian/Pacific Islander, and Hispanic represented 7.5 percent of the older
population AoA, 2013; U.S. Census, 2014).
Racial and ethnic minority populations have increased from 6.3 million in 2003
(17.5 percent of the older adult population) to 9.5 million in 2013 (21.2 percent of older
adult populations according to data from the Administration of Aging (AoA, 2013).
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Population projections statistics show increase of 21.1 million racial and ethnic minorities
in 2030 (28.5 percent of older adults) (AoA, 2013; U.S. Census, 2014).
Demographic Changes for Cancer
Disparities in cancer treatment and outcomes have become an increasing health
challenge among ethnic minorities. The reasons for health disparities are complex, but
demographic changes account for much of them. Many barriers to quality care include
jobs, housing, level of education, and racial discrimination accounts for health disparities.
Economic Burden of Cancer among Minorities Born between 1946 and 1964
The aging of America indicates more individuals can receive a diagnosis of
cancer. The increase in the overall population of aging minorities is likely to affect the
burden of cancer care, especially since research shows specific minorities have higher
prevalence cancers and lower survival rates than whites (ACS, 2015). The cost to
treatment cancer in the United States is massive, and cost continue to increase due to
individuals living longer as cancer survivors (Yabroff, Lund, Kepka, & Mariotto, 2011).
Factors contribute to the cost of cancer and make the disease a burden include health care
expenditures, productivity losses due to prolonged treatments, and out of pocket cost for
cancer patients and their families. According to the Congressional Budget Office (GBO),
national health care expenditures make up 18 percent of the Gross Domestic Product
(GDP), but projected estimates will rise to 25 percent of GDP by 2037 (GBO, 2012).
Moreover, direct medical costs associated with the burden of cancer include
hospitalizations, surgeries, physician visits, radiation therapy, chemotherapy, or
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immunotherapies that measure by insurance payments or patient out-of-pocket cost
(Yabroff et al., 2011).
Cancer costs vary according to the phase and type of cancer diagnosed. In 2010,
the net monthly cost for senior women with breast cancer was $1923 and $5,740 for lung
cancer (Yabroff et al., 2011). The total cost of cancer in 2010 estimated around $124.5
billion dollars. For example, higher cost is associated to treat female breast cancer at
$16.5 billion, colorectal cancer at $14.1 billion, and prostate cancer at $11.9 billion
(Yabroff et al., 2011). Future estimated cancer cost projected to reach $157.8 billion by
2020 (Yabroff et al., 2011). However, estimates from the AHRQ estimate the direct cost
to treatment of cancer in the United States (total of all health care expenditures) in 2013
were $74.8 billion (AHRQ, 2014; NCI, 2015). Cost, as a barrier that generally prevents
many from receiving access to quality cancer care, is also a barrier to Baby Boomers
aging minorities receiving optimal healthcare. Finally, targeted therapies for new cancer
treatments and technological advances in genetic mutations for improving treatment
responses for specific diseases are expensive and increase the cost of cancer care (AHRQ,
2014). Health disparities in cancer affect specific racial and ethnic minorities (CDC,
2016; U.S. Office of Minority Health [OMH], 2015). Here are some examples:
All cancers with lower life expectancy likely affect African Americans for men
and women of any race or ethnicity group as compared to whites (NCI, 2015; OMH,
2015). African American women are 40% have a greater risk of death from breast cancer;
whereas many African American men do not survive past 5-years from lung, colon, and
prostate cancers for example (NCI, 2015; OMH, 2015).
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American Indian/Alaska Native populations have lowest rates of cancer as
compared to whites. American Indian/Alaska Native men and women have high
incidence of liver, gastrointestinal, and renal diseases and greater risk of death from these
diseases (NCI, 2015; OMH, 2015).
Asian Americans have lower incidence of cancer rates than the non-Hispanic
white populations. Asian/Pacific Islander men and women have a higher mortality rate of
stomach cancer (NCI, 2015; OMH, 2015).
Native Hawaiians/Pacific Islanders have a high probability for receiving a
diagnosis for cancer. American Samoan women have a high mortality of cervical cancer.
American Samoan and Native Hawaiian men also have high rates of cancer (NCI, 2015;
OMH 2015). Native Hawaiian men are highly likely to die from any form of cancer
(OMH, 2015). In the U.S., territories of Guam and Micronesia populations have
incidence of liver cancer, versus the majority population (NCI, 2015; OMH, 2015).
Hispanic American men and women have lower cancer rates than the nonHispanic white population. For Hispanic men, the rate of prostate cancer is low. Hispanic
women have lower incidence rates of breast cancer, but higher mortality of cervical
cancer (OMH, 2015).
Public Health Efforts to Win the War on Cancer
Numerous studies have been published that document efforts by the United States
to win the “war on cancer.” The United States President (NCI, 2016) announced a “War
on Cancer” in 1971. Later that year, Congress amended the Public Health Service Act
and passed the National Cancer Act of 1971 (P.L. 92–218); that later authorized National
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Cancer Institute (NCI) to strengthen the scope of funding for cancer treatment research
(NCI, 2016; Frieden et al., 2008). However, funding for this massive initiative was
limited to cancer prevention research.
Secondary prevention efforts to reduce cancer mortality and help to achieve
winnable battle against cancer through successful through screening and early detection
initiatives. Several of these initiatives address breast and cervical cancer. Breast cancer
leads as a cause of death for many women of all ethnicities (CDC, 2014c). Annually,
many women are determined to have breast and cancer cancers and die from these
diseases (CDC, 2014c). Screening mammograms and Pap test helps to find female
cancers ahead of time when these diseases are most treatable to decrease mortality for
these two cancers (CDC, 2014c).
Other legislation enacted to aid to lower cases of cancer in the United States. In
1990, Congress passed the Breast Cancer Mortality Prevention Act of 1990 (CDC,
2016b). The law authorized the Centers for Disease Control and Prevention (CDC) to
create the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
(CDC, 2016b). The CDC provides dollars to the 50 United States, the District of
Columbia, five U.S. territories, and 11 American Indian/Alaska Native tribes or tribal
organizations (CDC, 2016b). The NBCCEDP provides women with access to cancer
screening and diagnostic services to ages 50-64 who are also low income and underinsured or uninsured (CDC, 2016). NBCCEDP data shows from 1991 to 2015 that more
than 4.9 million women were served, providing over 12 million breast and cervical
cancer screenings, and diagnosed more than 71,000 breast cancers, 3845 invasive cervical
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cancers, and 175,688 premalignant cervical lesions, of which 40 percent were high-grade
(CDC, 2016).
Another public health effort aimed at winning the war on cancer focused on
colorectal cancer. CDC’s Colorectal Cancer Control Program (CRCCP) provides funding
to states and tribal organizations to screen men and women for colorectal cancer (CRC)
through education and policy and systems change (CDC, 2013). CRC affects men and
women. CRC is number two in causes of death in the United States (CDC, 2014).
According to the U.S. Preventive Services Task Force (2016), a CRC recommended
screening test could save lives through a high-sensitivity fecal occult blood test,
sigmoidoscopy, and colonoscopy. These tests can locate cancer early before it moves to
higher level of progression and treat the disease quicker.
Cancer Treatment Disparities among Baby Boomer Minorities
Addressing the challenges of aging minority populations to promote cancer
treatment is critical for the future of cancer services (AHRQ, 2015). Some of the
challenges in general are a shortage of oncology personnel, the soaring cost to treat
cancer, and the changing demographics due to the number of aging Baby Boomer
minorities diagnosed with cancer. Another challenge is delivering accessible affordable
cancer care to aging minorities; assist them with shared treatment making decisions with
their cancer care providers. According to Smith et al. (2009) argued that the number of
cancer deaths would grow unless efforts to improve cancer treatment for underserved
older adults and racial ethnic minorities.
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Historically, older adults and minorities have been under-represented in cancer
clinical trials. Some barriers for clinical trials participation eligibility include
comorbidities of the patient, transportation to the study site, other financial obstacles, the
drug not paid by Medicare as an investigational treatment (Smith et al., 2009). Data from
the U.S. Food and Drug Administration (FDA), there are biological differences and
genetic variations in clinical trial participation (FDA, 2016). Some drugs can be more
toxic in one ethnic group than they would be in another; contraindications to other drugs
such as antidepressants and blood-pressure medications means they might be less
effective in one group than in another. However, clinical trials are the only method to
determine disparities in efficacy by racial and ethnic group (FDA 2016). Lack of minority
participation in clinical trials may also be due to a lack of trust. The Tuskegee Syphilis
Study conducted between 1932 and 1972 where the U.S. Public Health Service, is an
example where scientists recruited poor black sharecroppers in Alabama to study syphilis
(CDC, 2015). However, the investigators continued the study long after penicillin
discovery to treat syphilis (CDC, 2015; FDA, 2016). As a result, safeguards for clinical
trials participants among minorities and other population require institutional review
boards of scientists, physicians, and lay individuals to ensure safety and effectiveness in
drugs and protect rights of human subjects in research (FDA, 2016).
Patient-Provider Communication and Cancer Treatment
Efforts to eliminate cancer health disparities require effective patient-provider
communication strategies (AHRQ, 2015). Information that does not effectively address
the needs of Baby Boomers minority patients is a major concern in cancer treatment for
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this population. First, the healthcare professional workforce is under-represented among
racial and ethnic minorities that increases access to care (OMH, 2011). Race-concordant
relationships where health professionals treat patients different are often barriers to
effective communication (Schoenthaler et al., 2012). Therefore, policy efforts to increase
workforce diversity in clinical practice needs better patient-provider communication with
aging minorities. The lack of effective patient-provider communication strategies for
cancer treatment of minority and underserved populations may result in poor cancer care
outcomes (Sheppard et al., 2010). One benefit of effective patient-provider
communications in cancer treatment means patients make better informed decisions about
their cancer care and treatment; another benefit of improved communication is social
support networks are strengthened; anxiety is reduced, higher-quality cancer care is
delivered, resulting in an improved quality of life (Mead et al. 2013).
Communication styles and the quality of care affect the health outcomes (Bylund,
Peterson, & Cameron, 2012; Quillin et al., 2009). Few studies have focused specifically
on minorities born between 1946 and 1964 on patient and provider communication
influences the health outcomes of cancer survivors and their treatment decision making.
Patient-provider communication is a critical ingredient to the quality of life
affecting health care quality before and after cancer treatment and increase cancer
survivors in the United States (Epstein & Street, 2007). In earlier studies by Ong and
colleagues, (1995) doctor-patient communication includes several components such as
fostering a good interpersonal relationship, exchanging information to healing, and
making treatment or medical decisions. Some researchers suggest understanding cancer
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information can increase cancer survivorship associated with cancer care (Arora, Reeve,
Hays, Clauser, & Girvan, 2011; Song, et al., 2013).
Effective patient-provider communication happens when the patient assumes an
active role in their cancer care. Hibbard and colleagues (2013) concluded that patients
who are actively engaged in their care are confident in communicating with providers,
making, and maintaining decisions that are important to their long-term cancer survival.
Studies on long-term cancer survivors among racial ethnic populations reveal poor
communication, and lower self-efficacy in making medical decisions, and more inferior
quality of care on their follow-up patient cancer care as compared to whites Palmer et al.
(2014). Researchers also suggest providers should periodically provide communication
follow-up to encourage racial ethnic minority patients engaged about their cancer care
(Palmer et al., 2014). Consequently, providers should increase their knowledge of
cultural competence training for cancer care working with racial ethnic minorities
(Palmer et al., 2014).
Arora’s (2003) findings on provider communication indicate individual behavior
has a great impact on the patient’s health outcomes, as patients are already devastating of
having received a diagnosis of cancer. However, studies on provider perceptions of
patient-provider communication identify a breakdown in cancer care communication at
multiple levels including patient, provider, and health system level and suggest
integrating multi-level perspectives is essential to delivering patient-centered cancer care
(Prouty et al., 2014). Reyna, Nelson, & Han (2015) discuss more evidence-based
principals from several theoretical perspectives for interventions to support better
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decision making in cancer where the patient understands all the facets of the cancer
experience.
Cancer Survivor Studies
In a study understanding the importance of quality follow-up cancer care, Arora et
al. (2011) at the NCI developed the Assessment of Patients’ Experience of Cancer Care
(APECC) study, a population-based study of cancer survivors’ experiences of receiving
follow-up care. The primary goals of the APECC study were to develop and pilot test a
survey instrument that would assess cancer survivors’ perceptions quality of their cancer
care. The study also identified socioeconomic, clinical, and patient-level factors to rate
their quality of care, and evaluate the relationship between the survivors’ assessment with
the overall ratings (Arora et al., 2011). A pilot study to test the effectiveness of the
APECC survey conducted by NCI researchers and in collaboration with the Northern
California Cancer Registry, a partner of NCI’s Surveillance, Epidemiology, and End
Results (SEER) program. The study design included the recruitment of eligible cancer
survivors diagnosed with leukemia, bladder, or colorectal cancer 2-5 years before
enrolling in the APECC study, and be at least 20 years of age. Cancer survivors must
have received follow-up care within the last 12 months, and respond to cancer survivors’
experiences listed on the survey. A cross sectional mailed APECC survey and
information letter describing the study sent to 1,572 were eligible cancer survivors to
participate in the study, 774 or 49% responded or returned the questionnaire. The study
sample consisted of 623 cancer patients, or 81% of respondents indicated they had
received follow-up care in the last 12 months. Demographic data showed nearly 60% of
34

35
participants had colorectal cancer; 14% had leukemia, and 28% had bladder cancer, all
received cancer treatment in the past year; and 50% had multiple comorbidities (Arora, et
al., 2011).
The APECC survey included 33 areas to assess survivors' perceptions of the
quality of their follow-up care in the last 12 months. The results of researchers suggest
that underserved populations may be at risk of experiencing poor outcomes, and a better
continuity of care may lead to good patient experiences (Arora, et al., 2011). The
researchers concluded that physician knowledge of cancer patients is a key quality
indicator; improving patient-centered cancer care may improve patient’s experience
through communication and better coordination of care (Arora, et al., 2011). A limitation
of the study is not able to compare follow up care experiences some racial ethnic
minorities’ subgroups due to low sample size.
In another study, Palmer et al. (2014) examined racial and ethnic disparities in
patient-provider communication among cancer survivors using the survey data from the
Follow-Up Care Use among Survivors (FOCUS) study, a population-based study of
eligible cancer survivors conducted between March 2005 and 2006. The sample size of
1196 cancer survivors that were randomly selected from the Los Angeles and Northern
California Surveillance SEER registries. The eligible cancer survivors diagnosed with
colorectal, prostate, endometrial, or ovarian cancer, age 21 at diagnosis, males and
females among non-Hispanic white, African America, Hispanic and Asian completed the
survey on physician use for cancer related follow up care. The results indicate that
African American, Asian and Hispanic survivors report poor patient-provider quality
35

36
ratings and health outcomes as compared to Whites (Palmer et al., 2014). The researchers
concluded that more research to address racial ethnic disparities in cancer survivors to
improve patient experiences and quality of life outcomes (Palmer et al., 2014).
Patient-Centered Care
The IOM reported in their Crossing the Quality Chasm and recommended
improvements in “health care delivery that should be patient-centered, meaning care
should be responsive to individual patient preferences, needs, and perspectives and
ensure that patient values guide clinical decisions” (IOM, 2001). The National Cancer
Institute (NCI) created a conceptual framework for understanding patient-centered care
for patient-provider cancer communication and developed an evidence-based monograph,
Patient Centered Care Communication in Cancer Care, (Epstein and Street, 2007)
working with multiple experts in oncology, primary care, and patient advocates (Arora,
Street, Epstein, & Butow, 2009). The monograph describes the interaction of patients,
families, clinicians, health care organizations understand cancer communication research
for cancer treatment and shared decision-making (Epstein & Street, 2007; Figure 4).
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Figure 4. Model of patient-centered care. Source: Epstein, R.M., Street, And R.L. Jr.
Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing
Suffering. National Cancer Institute, NIH Publication No. 07-6225. Bethesda, MD, 2007.
Shared Decision Making
Shared decision-making is effective when patients know about cancer treatment
options, risks, benefits, and their values and preferences considered into treatment
decision-making (Katz, Belkora, & Elwyn, 2014). For many patients with cancer,
discussions can be complicated about specific options for treatment and continuing
cancer care. Several studies continue to plague disparities among certain racial groups on
treatment choice and their attitudes in communication with providers regarding cancer
treatment decision making (DeSantis and Naishadham, 2013; Haider, Scott, Rehman, et
al., 2013). In many cases, minority patients experience less satisfaction of care including
trusting the clinicians in communication about their cancer care (Thomas, Goff, Tsang, et
al., 2013).
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According to Luo, Spolverto, Johnston, Haider, and Pawlik (2015) shared
decision-making studies account for several factors that determine cancer treatment
choice for racial ethnic minorities including not treating the cancer or best supportive
care, non-surgical treatments such as chemotherapy, radiation therapy, or surgery. Patient
and provider communication is critical in what choice of therapy the patient chooses for
minority patients. Differences in cancer treatment vary across different minority groups,
and patient-physician communication, decisional control preferences, and cultural
attitudes contribute to cancer options for minority patients (Luo et al., 2015). The
researchers argue that while the physician is the initial person of information patients rely
on, physicians may act poorly in providing accurate and timely information to minority
patients making them limited informed about specific treatment options for their
treatment satisfaction (Luo et al., 2015). The final cancer treatment decision lies with the
patient and the family when they are engaged in their decision (Luo et al., 2015). The
quality of patient-provider communication and decision-making can influenced by related
to cultural attitudes. Culture barriers among certain minority cancer patients include
fatalism, medical mistrust and lack of the health care providers and individuals who have
suffered from medical discrimination (Yanez et al., 2012).
Mead et al (2013) conducted a systematic review of studies for shared decisionmaking and concluded that a shared decision approach to cancer care should extend
beyond the general patient-provider to import key individuals and community members
in the cancer treatment decision-making process. A conceptual model to access decision
making for cancer treatment among racial ethnic populations was created to identify the
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multiple determinants of cancer treatment (Figure 5) that include levels of influence for
the patient, family, community, and provider (Mead et al., 2013). Researchers argue that
the SMD approach is not necessarily appropriate for every cancer patient (Mead et al.,
2013). Addressing culture and personal preferences for treating cancer through effective
patient center communication may improve adherence to treatment, may reduce the
delays of cancer care for racial ethnic minorities (Mead, et al., 2013).

Figure 5. A conceptual model cancer treatment decision-making racial ethnic minority
patients. Source: Adopted from Mead et al., 2013.

Cancer cases are expected to increase as the U.S. population ages and leads as a
cause of death. As an example, for older women with breast cancer will affect many older
women and increase among racial and ethnic minority women (CDC, 2014). Multiple
health disparities exist for breast cancer treatment among older minority women;
socioeconomic status, poor treatment decision-making outcomes, access to health
services, family involvement, language barriers, and acculturation of immigrant
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populations (Luo et al., 2015). African American and Latina women receive poorer
patient-physician communication and are less likely to receive aggressive breast cancer
treatment like breast-conserving surgery, and radiation treatment as compared to whites
(Yanez, Stanton, & Maly, 2012). Understanding more about cancer treatment decision
making for aging minority populations can improve cancer disparities and health equity
among vulnerable populations.
Summary
This chapter has presented the Baby Boomer population is living longer than any
birth cohort in United States history, so it poses new challenges not seen in before
modern healthcare. The health disparities in this cohort, born between 1946 and 1964 are
well known. Moreover, the cancer rates expected to rise as this population ages and
become more diverse. Having a good patient-provider communication system is essential
to lowering cancer health disparities among the study population that makes decisions
about cancer treatment. Cultural and ethnic factors, treatment delays due to in effective
communication, workforce shortages, distrust of providers and healthcare system factors,
the rising cost of cancer all contribute to cancer health disparities and quality cancer care
for aging Baby Boomer minorities.
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Chapter 3: Methodology
Introduction
The purpose of this study was to understand the personal experiences of aging
minorities during cancer treatment decision making when communicating with their
cancer care providers. The preceding section focused on the current literature related to
Baby Boomer ethnic minorities’ decision making for cancer care treatment. The age
cohort for this study was individuals between 50 and 74 years of age. Cancer health
disparities in this cohort include an awareness of patient-provider communication and the
quality of cancer treatment decision-making this communication facilitates. In this
chapter, I outline a phenomenological research paradigm for this study along with the
specific aims of the study, the setting, and the sample used to examine the lived
experiences of participants. Additionally, in this section I discuss the participant selection
process (inclusion and exclusion criteria), the role of the primary investigator, measures
taken to protect all study participants, and data collection and data analysis procedures.
Research Plan and Design
I selected a phenomenological research method. Phenomenology studies focus on
lived experiences or events in people’s lives and provides a framework for evaluating
perception in a way that can further aid in understanding participants’ perspectives. The
core attributes of phenomenology make it a good choice for qualitative inquiry as it
allows for insight into the possible influences of perceptions on behaviors and actions
(Creswell, 2009). A phenomenological researcher is concerned describing a person’s
experiences about how they see the world (Giorgi, 2008; Speziale & Carpenter, 2007).
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The interview was the data collection tool that I used to explore experiences of
participants as a basis for this qualitative study. According to Giorgi (2008), questions for
qualitative interviews should be broad and open-ended, allowing the participants
opportunities to share their points of view. Active listening on the part of the researcher
and probing for clarity are essential to getting participants to describe their experiences
(Bevan, 2014).
The central phenomena studied were experiences of minorities born between 1946
and 1964 when making decisions concerning cancer treatment. I sought to understand the
disparities in cancer diagnosis and treatment among this population group, especially as it
related to the influence of patient-provider communication on treatment decisions for
underserved racial and ethnic minorities diagnosed and treated for various types of
cancers. Understanding specific healthcare-related factors in cancer treatment decisions
may help determine interventions for the study population. The qualitative approach
supported exploration and probing of study participant experiences, and the
phenomenological research design resulted in obtaining good descriptive information
(see Creswell, 2009).
Research Questions
The research questions guided the in-depth interviews, which were the primary
collection tool to identify cancer treatment decision-making based on patient-provider
communication. The specific inquiries for this qualitative research were:
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Research Question 1: Do inadequate time allowed for medical decision-making
and lack of active listening and empathy by care providers prove to be barriers to
patient-provider communication for Baby Boomer minorities?
Research Question 2: What are facilitators for post-cancer treatment (e.g., access
to quality care and supportive networks) that improve quality of life of Baby
Boomer minority cancer survivors? What are the barriers to improved quality of
life?
I used open-ended questions to gather data that provided insight about the
experiences of the research subjects (see Penner & McClement, 2008; see Speziale &
Carpenter, 2007). Campbell (2016) suggested that open-ended questions must have a raw
theme to urge participants to describe how the phenomenon had influenced their lives and
how the experiences uniquely affected them. In this study, in-depth interviews were the
primary collection tool to answer the research questions.
Descriptive variables such as race and ethnicity, educational attainment, age, sex,
marital status, and insurance coverage information collected to inform the study. I asked
specific questions about participants’ experience with cancer treatment decision making.
For example, one question was, “I like to you to share your cancer treatment decisionmaking experiences in the past 2 years.” (Arora, et al., 2011; see Palmer, 2014; see
Sheppard, et al., 2010). These interview questions measured patient-provider
communication and cancer treatment decision making from follow up care experiences as
perceived by the study participants. I used probes to solicit more details or to clarify
answers, and I categorized responses into themes in a matrix. I asked the following
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interview questions to uncover participant perceptions of cancer treatment decision
making and provider communication:
1. Describe how you first learned about your cancer diagnosis.
2. Did your cancer doctor discuss treatment options you could understand for
making decisions about your cancer treatment process? If so, what did the
doctor discus?
3. How long after the cancer, diagnosis was your cancer treatment decision
made.
4. Did your cancer doctor encouraged your involvement to ask important
questions about your cancer treatment options? If so, how?
5. Did your doctor encourage you to voice your opinion (agree or disagree)
about your cancer treatment or specific treatment recommendations?
6. Please describe how family members or significant individual(s) influenced
your cancer treatment decision.
7. In what ways did family members or significant individual(s) communicate
with your doctor about your cancer treatment options?
8. In what ways do you feel your age played a role in your cancer treatment
decision making?
9. In what ways do you feel your financial resources played a role in your cancer
treatment decision making?
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10. Did your spiritual or religious beliefs influence your cancer treatment
decisions? If so, please if it helped or hindered you dealing with this serious
physical illness?
11. In looking back, what things do you think the medical care team could do to
improve quality cancer care with patients?
12. Are there any additional comments you would like to provide about your
cancer treatment decision experiences?
These interview questions modified using the APECC population-based survey
developed by researchers at the NCI (2011). The APECC survey was designed to
measure perceived quality of cancer care follow-up from the cancer survivors’
experiences, assess the satisfaction of care within 12 months, and to understand cancer
patients’ participation in their decision making for cancer treatment and follow up cancer
care (NCI, 2011). Researchers assessed key factors critical to patient-provider
communication necessary to promote quality of care after treatment for cancer survivors
(Arora et al., 2011; Palmer, 2014). For example, areas of follow-up care experiences
assessed were: (a) access to care, (b) physicians’ communication, (c) medical care team
communication, (d) health promotion, and (e) coordination of care. Some questions used
in the survey that informed physician communication ratings included: “In the past two
years, how often did your cancer-related follow-up care physician(s):
(a) Listen carefully to you,
(b) Explain things in a way you could understand,
(c) Show respect for what you had to say,
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(d) Encourage you to ask all the cancer-related questions you had, and
(h) Involve you in decisions about your medical care as much as possible.
This tool allowed me to gain a deeper and richer understanding of cancer survivors’
experiences of this aging population-based study with members of racial and ethnicities
minorities in order to understand the barriers and facilitators for increasing quality cancer
care.
Role of the Researcher
My role in this study I gathered and analyzed the data from the participants by
conducting personal interviews. I narrowed the research problem down to the gaps in the
literature. As a public health professional, I understand the challenges of aging and the
growing cancer concerns of Baby Boomers as they age. To mitigate potential researcher
bias I was open to and flexible in meeting the needs of the participants. I did not
encourage participants to share information they were not ready to share or make them
discuss topics that were not relevant to the specific research.
Participant, Recruitment Strategy, Sample, Size
Understanding racial ethnic differences for cancer treatment and decision-making
is imperative to reducing health disparities among aging minority patients. Qualitative
methodology is well suited for a phenomenological study for which previous research is
limited on the experiences of aging minority populations when discussing cancer
treatment options with their physicians. Potential participants eligible for recruitment will
be individuals between the ages of 54-72. Study participants are diagnosed with a cancer
such as breast, cervical, colorectal, prostate or other diagnosed cancer within Stage I or
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higher, and are experiencing cancer treatment in the past 24 months from no surgery,
chemotherapy, radiation therapy, or surgery. Study participants were English speaking
and are mentally competent. Study participants can be male or female.
The study size population will be up to 15 individuals born between 1946 and
1964 who are cancer survivors and for purposes of this study are sufficient sample size to
answer the research questions. In a similar study, Obikunle (2016) examined the personal
experiences of 14 African American women, 40 years and older, perceived barriers to
breast cancer screening. A sampling strategy, I selected for this qualitative study is
random sampling technique that allows the researcher to use semi-structured interviews
for the described research design. The specific criteria for the study that individuals are
members of various ethnic and racial minority groups to facilitate the information
necessary for response to the interview questions. This study, conducted in the
metropolitan area of Atlanta, Georgia at a Community Health Center (CHC) that serves
primarily low socioeconomic status cancer survivors. Previous studies show that
underserved minority populations exhibit a higher disease burden as compared to whites;
they often have late stage diagnosis and poor survival outcomes for cancer (Byrd et al.,
2011; Thompson et al., 2013). Baby Boomer minorities also receive fewer cancer
treatment services compared to whites (NCI, 2016). The first eligibility criterion to
participate in the study is to be an individual who self-identifies as one of the following
racial or ethnic backgrounds: African American, Asian, Hispanic or Latino, American
Indian/Alaska Native. Participants must also self-identify as a cancer survivors.
Additional criteria are to be between 54 and 72 years of age, speak English, and identify
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the CHC as their access to oncology care. Qualitative methodology is well suited for a
phenomenological study for which previous research is limited on the experiences of
aging minority populations when discussing cancer treatment option with their
physicians.
As a sampling strategy, I selected for this qualitative study is semi-structured
interviews for the described research design. The specific criteria for the study that
individuals are members of various ethnic and racial groups to facilitate the information
necessary for response to the research questions.
Study participants recruited from the follow up care conducted at a Federally
Qualified Health Center (FQHC) or Community Health Center (CHC) that serves
primarily low socioeconomic status minority populations in a metropolitan area of
Atlanta, Georgia. Previous studies show that underserved minority populations many
times exhibit a higher disease burden as compared to whites; they often have late stage
diagnosis and poor survival outcomes for cancer (Byrd et al., 2011; Thompson et al.,
2013). Baby Boomer minorities also receive fewer cancer treatment services compared to
whites (NCI, 2016).
Participant selection was from a range of racial and ethnic aging minorities that
consisted of African Americans, Hispanic or Latina, Asian/Pacific Islanders, American
Indian/Alaska Native. All participants included, informed of the purpose of the study,
their rights as participants, and that they understand the consent form included in the
study.
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A goal for the sample size was 15 participants for this study. After obtaining
demographic data from the participants, semi-structured face-to-face interviews
conducted at a CHC setting to allow participants to articulate their cancer treatment
experience, decision making, and patient-provider communication. The participants had
the opportunity to share additional information about their cancer care experiences and
follow up from the researcher if necessary.
Data Collection
The study intended to analyze data regarding the phenomena, context, and themes
through direct observation and interaction experienced by minorities born between 1946
and 1964 and their experience in receiving cancer care. After the Walden University’s
Institutional Review Board (IRB) approval, I collected data in Atlanta, Georgia. The IRB
is a formal committee established for responsible, ethical review and oversight of studies
according to the U.S. Department of Health and Human Services Office for Human
Research Protection, Regulations 45 CFR Part 46 (2018).
Participants were asked open-ended questions to explore their experiences with
patient-provider cancer treatment and care. All of the interviews were conducted in
Atlanta, Georgia. The researcher worked closely with the CHC to identify eligible cancer
participants to send an invitation letter describing the study. The researcher contacted
study participants. Participants who agreed to the interview completed the informed
consent for research. Interviews were recorded and transcribed into a Microsoft Word
document and identify common themes for the research study. Names were not be
assigned to the interview instrument, but participants were assigned a numeric code for
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identification of each study participant. The sample size was small, limited to 15
participants to maximize the saturation of data.
For confidentiality, interviews were face-to-face. The investigator probed
participants’ cancer treatment experiences. Each interview lasted no more than 60
minutes. An interview instrument by the researcher ensured each participant answers all
the same general questions to solicit their individual experiences about cancer treatment
and communication with their provider. Interviews were in a comfortable environment
conducive to capturing the essence of their experiences while maintaining accuracy,
privacy, and confidentiality of the data. The participant had the opportunity to provide
feedback to add to richness to the data collected.
Data Management and Analysis
The analysis of all patient data collected through audio-recorded interviews by the
researcher, and transcribed into a Microsoft Word document. Once transcribed, the
researcher read the interviews while also listening to the recordings. Then the paper copy
of the research material documents kept in a secure storage file. All interviews verified
for accuracy, patient responses were analyzed using NVivo software for qualitative study
data analysis. Specific data themes analyzed to examine Baby Boomer minorities’ cancer
treatment experiences.
Transcripts data analyzed from themes that pertained to Baby Boomers
minorities’ cancer treatment experiences. The themes that emerge related to the barriers
and facilitators of patient-provider communication, health system factors that influence
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cancer treatment decision making. A stratified analysis by racial ethnic differences of
patient-provider communication perceptions and cancer treatment decisions conducted.
Reliability and Validity
Specific steps to ensure reliability and validity in this study in the study. Validity
in this qualitative research study determined the trustworthiness of the instrument to
design to gather the data collection from participants. The face-to-face interviews were at
the Community Participants’ conference room or study participant’s home. The face-toface interviews of participants’ data recorded for accuracy from the research findings.
The data transcribed for reliability, and the transcripts read while simultaneously listening
to the audio-recorded interviews. A final copy of the transcript provided to the
participants to identify their experiences relative to the study and share feedback, if
necessary.
Summary
Information in this chapter includes the research design, and specific
methodology of the study. The researcher presented a rationale for each section.
Furthermore, data collection, management, and analysis techniques identified. The
selection of the participants, where the interviews took place and shared experiences was
determined. Finally, this chapter supports the choice to use a qualitative approach to
gather information from the study population. Semi structured interviews guided this
qualitative study to gather patient experiences of cancer treatment for this research.
Chapter 4 the results from the analysis and implications of findings for public health for
cancer and aging Baby Boomer minorities are highlighted.
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Chapter 4: Results
Introduction
The purpose of this qualitative study was to examine health disparities among
aging minorities during cancer treatment about decision making when communicating
with their cancer care providers. In this chapter I describe the interview instrument,
community partners, study setting, recruitment of participants, and data collection
technique and analysis. I conducted in-depth face-to-face interviews with 10 cancer
survivors during the months of January and April 2018. Individuals born between 1946
and 1964 were eligible for the study. This chosen study cohort of interest was the aging
Baby Boomer population who had experienced cancer. Participants must have been in
cancer treatment for at least 2 years.
Research Tool
The data collection tool consisted of an interview guide (see Appendix B) I
developed with twelve demographic questions and twelve open-ended questions for
individuals who experienced any form of cancer. The first half of the interview guide
consisted of basic demographic questions of age, education level, and type of cancer. The
remaining section of the interview guide included interview questions that addressed two
research questions:
Research Question 1: Do inadequate time allowed for medical decision-making
and lack of active listening and empathy by care providers prove to be barriers to
patient-provider communication for minority Baby Boomers?
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Research Question 2: What are facilitators for post cancer treatment (e.g., access
to quality care and supportive networks) that improve quality of life of Baby
Boomer minority cancer survivors? What are the barriers to improved quality of
life?
Recruitment of Participants
I recruited two community partners in North Georgia to locate participants to
interview for the cancer study. After the IRB application approval, I sent an introduction
letter and letter of cooperation (see Appendix A) requesting participation in the study to
seven county area multipurpose resource centers in neighborhoods that serve a diversity
of aging ethnic minorities explaining the purpose of the study to directly observe cancer
treatment decision-making experiences among minorities. I received two signed letters of
cooperation from organizations willing to participate in the study. The community
organizations that were unwilling to participate in the study declined to provide signed
letters. Prior to the interviews at the community organization partners, I contacted the
directors of the organizations to set up a time to place a copy of the recruitment flyer
seeking eligible study participants willing to talk about cancer care experiences with their
care provider.
Setting
This study conducted in two counties of the Atlanta, Georgia area with a diverse
population that include older minorities. Cancer is the second leading cause of death in
Georgia; 45,000 individuals diagnosed with cancer and 15,500 die annually from this
disease according to the Georgia Cancer Data Report (McNamara, Bayakly, & Ward,
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2016). Some cancer deaths in Georgia are preventable by detecting cancer early when
treatment is most effective. Racial disparities in breast, cervical, prostate, colorectal,
lung, and kidney cancers are apparent, with African American women and men in
Georgia having higher age-adjusted incidence and mortality rates than Whites
(McNamara et al., 2016).
Community Partner Organizations
For this study, Community Partner Organization A and Community Partner
Organization B both agreed to be included in the study. Both these organizations are
multiple-purpose centers that offer services for communities, specifically seniors over 55
years of age. They also provide information, referrals, and professionals to facilitate
better quality of life for senior citizens in these counties. Community Partner
Organization A is a multi-purpose senior center that offers programs for active seniors
that promote mental, physical, and emotional well-being. Community Partner
Organization B is a multiple-service organization servicing community members with
such services as family health education including offering a cancer support group. To be
eligible for the cancer study, prospective participants needed to: (a) be male or female;
(b) born between 1946 and 1964; (c) speak English and identify as Asian American,
African American, Native American, or Hispanic/Latino; and (d) diagnosed with any
form or stage of cancer and have made cancer treatment decisions within the last 2 years.
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Data Collection
I received approval from Walden University IRB (approval number 10-11-170147607) prior to visiting the respective community partner organizations to collect data.
I contacted the directors of the community partner organizations to schedule a time to
visit to speak with them about my specific research agenda and address any questions or
concerns they may have. Both Community Partner Organization A and B directors agreed
the best time to visit and post recruitment flyers were during the busiest hours when
many participants would gather for activities. I placed recruitment flyers where most
prospective participants gathered with the goal of meeting those who met the criteria and
where ready to participate.
To facilitate the recruitment of potential participants, an information-sharing
seminar with other volunteer service organizations such as AARP (American Association
of Retired People) and VISTA (Volunteers in Service to America) during lunch hour was
a good opportunity to meet members of Community Partner Organization A and share
information about the cancer study. I also spoke with the cancer support group of
Community Partner Organization B to share information about the importance of cancer
screening and that as a person ages they are most at risk for developing many types of
cancers. I was able to schedule interviews with prospective study participants to set a
time convenient for them for interviews. During the initial visit, I explained the purpose
of the study with each participant, reviewed the informed consent document with them,
and addressed any questions they had about their participation in the study.
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Sample Selection of Participants
For this qualitative study, I used purposeful sampling techniques to identify the
cancer study participants. The eligible participants included men and women from the
Baby Boom cohort, defined as those individuals born between 1946 and 1964. After each
interview, study participants were given a $25 gift card for their time and participation.
Additionally, I advised participants that their names or other identifying information kept
confidential. Participants understood that a pseudonym would identify their research
participation in the study to maintain confidentiality. The participants who agreed to
move further in the study process (N = 10) read, understood, and the signed consent
forms. The study participants retained a copy of the consent form.
I conducted interviews during weekdays when participants visited Community
Partner Organizations A and B. The interviews were face-to-face, in-depth, and openended. An interview guide provided the data for consistency among study participants
(see Appendix B). The required sample size to understand the personal experiences of
aging minorities regarding cancer treatment decision making when communicating with
their care providers was 10 participants. All interviews were audio recorded with
permission of the participant. The interviews lasted 45 minutes to 1 hour. During each
interview, I would probe and asked additional questions to gather rich data from the
participants while capturing the participants’ reactions during the reflective writing.
Demographics
The interview guide included twelve demographic questions. The sample included
a total of 10 men and women. The age range of participants was 55-72 years of age with
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a mean age of 64.3 years. There were seven females and three males. The participants
were African Americans (n = 7), Hispanics (n = 2), and Asian (n = 1). Some of the study
participants reported to be married (n = 4). Only three participants were still working fulltime jobs and seven were retired. The level of education of the study participants ranged
from high school graduates (n = 3) to graduate degrees (n = 4). The participants reported
an annual income range of under $25,000 to over $100,000. The health insurance status
of participants varied, with Tricare/VA (n = 1), Medicare (n = 4), Medicaid (n = 2),
private employer insurance (n = 4) with one individual reporting having dual coverage.
One individual also reported not having insurance during the interview after a lapse in
Medicaid coverage. Table 3 highlights the demographic information collected during the
in-depth interviews.
Data Analysis
For this study, I used the qualitative software NVivo 11 for Windows designed by
QSR International. I reviewed all the transcriptions several times to identify common
themes in relation to my two research questions. I used subcategories to describe the
participants’ verbal responses to the cancer treatment experience. As proposed with the
van Kaam method (Moustakas, 1994), I used the full descriptive analysis regarding the
lived experiences to generate the main themes. The NVivo 11 for Windows software
allows the researcher to code, sort, and analyze data summaries from each transcript. The
NVivo software offers useful tools to prepare the analysis, work with the interviews, and
find emerging themes for the study.
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I saved the audio recordings and transcripts and uploaded them to NVivo 11
software for qualitative research to maintain data management and storage. According to
Woods, Paulus, Atkins, & Macklin (2016), qualitative data analysis software such as
NVivo is capable of allowing the researcher to synthesize multiple processes ensuring
adequate data management and analysis techniques are in place to complete the research
project. The NVivo software assisted in reducing manual processing time and allowed me
and to center efforts at improving the quality of the study (see Welsh, 2002).
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Table 3
Demographic Characteristics of Cancer Survivors
Participant Characteristics

Frequency

Age (Born 1946-1964)
50-59
60-69
70-72

2
4
4

Gender
Male
Female

3
7

Race
African American
Hispanic
Asian

7
2
1

Family Income
Below $25,000
$25,000-$35,000
$35,000-$50,000
$50,000-$75,000
Above $75,000

3
1
3
1
2

Marital Status
Married
Divorced
Single
Widowed

4
2
2
2

Educational level
Less than high school
High school/GED
Some college
College graduate

3
3
4

Health Insurance Status
Tricare/CHAMPVA
Indian Health Service
Medicare
Medicaid
Private / Employer
Self-Pay
No Insurance

1*
4
2
4

*Dual health
coverage
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Participants reported seven different cancer types: breast cancer (n = 7), colorectal
(n = 1), prostate (n = 1), lung (n = 1), and kidney (n = 2) cancer. Two participants
reported a dual cancer diagnosis and shared a painful discussion about having concurrent
cancer treatments. All 10 women and men reported less than 6 months to commence their
cancer treatment decision. All participants received conventional cancer treatment
including surgery, chemotherapy, and or radiation; only one participant received hormone
therapy as an alternative treatment. The cancer characteristics of study participants are
identified in Table 4.
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Table 4
Cancer Participant Summary
Characteristics

Frequency

Cancer Type
Breast
Prostate
Colon/rectal
Cervical/Ovarian
Leukemia
Lung
Kidney

7
1
1

1
2*

Time making Cancer Treatment Decision
<6 months
>6 months

10

Cancer Treatment Decisions
Conventional Treatment
Surgery
Chemotherapy
Radiation

10

Adjuvant/Alternative Treatment
Hormone therapy
Immune therapy
Targeted therapy

1

* Two study participants had dual cancers
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Table 5 provides a summary of cancer characteristics for each participant. The
participant’s names were changed to protect their confidentiality. The table describes
their cancer type, stage of cancer at diagnosis, specific cancer treatment, and length of
time with the cancer provider.
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Table 5
Cancer Participant Summary
Participant*

Cancer Type

Stage of
Cancer
At Diagnosis

Cancer
Treatment

1 Helen

Breast

Stage II

Surgery,
Chemotherapy,
Radiation

3-4 years

2 Amy

Breast

Stage III

Surgery

5 years

3 Kim

Breast

Stage IV

Surgery,
Chemotherapy

2 years

4 Beverly**

Breast/Kidney

Stage III

Surgery;
Mastectomy,
Chemotherapy

5 years

5 Jawanda

Breast

Stage III

Surgery,
Chemotherapy

3 years

6 John**

Prostate/Kidney

Stage IV

Surgery,
Radiation,
Hormone

5 years

7 Mateo

Lung

Stage I

Surgery

2 years

8 Sofia

Breast

Stage III

Surgery,
Radiation

2 years

9 Faye

Breast

Stage IV

Surgery,
Radiation

2 years

10 Cho

Colorectal

Stage IV

Surgery,
Radiation

3 years

*Actual names changed to protect participant confidentiality.
**Dual cancers
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Time with
Cancer
Provider
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Themes
The data analysis from the in-depth interviews revealed nine major themes that
emerged: (a) Cancer diagnosis, (b) Understanding and response, (c) Provider information
giving, (d) Engaged patients, (e) Influence of social networks, (f) Cancer knowledge, (g)
Financial burden, (h) Spirituality, and (i) Quality of cancer care. These themes
highlighted the complex nature of patient-provider communication when discussing
treatment decision making for older minority Baby Boomers.
Research Questions
The two research questions answered by the data collected from interviews and
listed in this section. All participants were asked thinking back when they were diagnosed
with cancer and communication they received from the doctor regarding cancer treatment
decision making.
Research Question 1
To identify what participants perceived as cancer treatment decision making, the
first research question asked if inadequate time allowed for medical decision-making and
lack of active listening and empathy by care providers proved to be barriers to patientprovider communication for minority Baby Boomers. From the first research question,
four themes emerged.
Theme 1
Cancer diagnosis. This theme highlighted the importance of participants are
being screened for cancer during a routine or annual examination is significant to detect
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the disease in early stages. Study participants shared how they first learned of their cancer
diagnosis:
Helen: I went for my annual mammogram check-up. I have had annual
mammograms for the past 30 years. I was called back for another test because
there was a spot on the breast x-ray. A biopsy was done and confirmed I had the
breast cancer. I was so shocked!
Amy: I had a routine mammogram. The doctor took tissue from breast, did the
biopsy, and said it was malignant breast cancer. I was scared and shocked I would
get the cancer. That was my third time having mammograms since my late forties.
Kim: My husband felt the lump under my breast. It was painful. I was also in an
auto accident and the ER doctors saw the spot in my chest area. Further testing
from the mammogram, MRI, ultrasound, a biopsy, a PET scan, confirmed breast
cancer.
Beverly: I did a breast self-examination and felt a large lump in my left breast.
The doctors say it was breast cancer Stage III. I had one breast removed with the
chemotherapy. A year later, found out I had the cancer in my kidney.
Jawanda: I felt a lump in my breast self-exam and then I went to the doctor. I got
the mammogram. I had a lump in both breast. One side was much larger than the
other was. It was surgery on one breast.
John: I actually had cancer three times. The first was kidney cancer disease. I had
prostate cancer twice. I first found out about the cancer when I went to the doctor
for stomach problems. My doctor noticed the treatment was not going very well
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from the diarrhea. So, doctor checked for MRI, found spot in one of the kidneys.
Dr. said, it was kidney cancer and treated 3-5 years. The cancer came back and I
went in for treatment for the prostate. The third time or this most recent cancer
was the follow up the prostate exam where the PSA check had extremely
elevated.
Sofia: I moved from another country a couple years ago. After my husband got
insurance I went to the doctor because my nipple was turning pinkish. Doctor did
the mammogram, a biopsy, MRI and confirmed me positive for the breast cancer.
Faye: I found out during my annual mammogram. I had large breast with cystic
fibrosis. All testing confirmed breast cancer Stage IV.
Theme 2
Understanding and response. In this theme, study participants revealed their
perception of comfort level in understanding the provider communication and making
decisions about cancer treatment:
Helen: I did not understand at first. The doctor said I have Stage II breast cancer.
The primary doctor gave me a list of cancer doctors to choose. I researched and
found a particular female doctor where she explained to me the mastectomy vs the
lumpectomy procedures. I felt comfortable with her and chose to have the
lumpectomy procedure. The doctor did not rush me into making the decision.
Amy: To me the cancer surgery doctor did not discuss very much. I did not
understand everything in a way that made sense to me. He said we could do a
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lumpectomy with chemo and radiation and remove my left breast. Later, I chose
to have the breast completely removed.
Kim: The cancer doctor did not discuss much and did not give me many options
other than surgery with aggressive chemotherapy. I was somewhat able to
understand and feel comfortable with the cancer treatment decision.
Sofia: The doctor did not discuss. In addition, I did not know what to ask the
cancer doctor. I just trusted everything the doctor said. He was Hispanic and
spoke Spanish like me. It was easy for me to communicate with him easy to trust
and to communicate. He never told me we have this option or that. I told him to
do what we need.
John: After three cancers, I learned after each cancer – doctor say I have cancer.
Then what is the best treatment option? I will locate the best doctors. The doctors
were competent.
Mateo: No. Well, the doctor just explained I need surgery in a hurry.
Jawanda: No. The doctor communicate he was 99/100% sure that everything is
ok. I did not feel comfortable.
Faye: A biopsy confirmed the diagnosis to determine the cancer. As a nurse, I
understood procedures. However, after discussion, the doctor gave me an option
of lumpectomy vs. mastectomy. I chose to undergo the lumpectomy.
Participants responded to a follow-up questions regarding how long they waited
before making the cancer treatment decision. Participants verbalized their specific values
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and time preferences to moved forward with the cancer treatment recommendation after
communicating with the doctor after the cancer diagnosis:
Helen: I waited to after my two-week vacation and returned for breast cancer
surgery. The doctor encouraged me not to put off longer having the procedure. I
was ready to move on have it done.
Beverly: Immediately.
John: The decision was quick without hesitation.
Amy: I waited a couple weeks and decided to have the breast removed. I wanted
the cancer out of my body.
Sofia: When doctor decided surgery and treatment I need, it was a month later
before I decided. I told doctor I just wanted to have Thanksgiving with my family.
The doctor described removing left my breast.
Faye: It was an immediate decision at the time of notification of diagnosis and
procedures.
Kim: After the cancer doctor recommendation after the diagnosis, I waited a
couple of weeks before deciding to have the surgery and aggressive
chemotherapy. I had the chemotherapy, then surgery. However, the doctor found
more cancer.
Theme 3
Provider information giving. This theme includes perceptions of participants
made to whether the doctor encouraged them to get involved by asking any questions
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about their cancer treatment option. Each participant expressed his or her perception of
the cancer doctor:
Amy: The doctor was not very encouraging to me. He told me we could do
lumpectomy or mastectomy, A or B – that is it! The treatment decision based on
the information given to me at the time.
John: All doctors encouraged my participation. I was confident with the surgical
doctor for the entire procedure.
Jawanda: Yeah! All doctors on my cancer care team communicated with me
individually and discussed everything and I had many questions to ask them.
Kim: Not really. This doctor gave me some websites and other organizations to
look on the computer about cancer, what I should expect. I was told; learn about it
on my own time. He referred a monthly breast cancer support group. I did not
participate.
Sofia: Doctor no talk too much to ask me questions. It was so overwhelming. I did
not know what to ask. He just say if I remove the breast and have the
reconstruction. So another breast cancer survivor say no to breast reconstruction. I
wanted to save my nipple. Doctor let me take control. I did not get another second
opinion.
Faye: Yes. The doctor was very good, said bring someone with me, and write
down all my questions before coming to next visit. As a nurse, I did not always do
that, but glad the female doctor was very knowledgeable. I had the best
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information about breast cancer. In addition, the woman at the American Cancer
Society provide me some useful information.
Theme 4
Engaged patients. This theme relates to if the doctor encouraged aging minority
Baby Boomers to voice their opinion (agreed or disagreed) with the cancer decision test
or specific treatment recommendation(s). Participants expressed their experiences during
the shared decision-making process:
Faye: After speaking with doctor, the decision was simple. She explained to me
the difference between the lumpectomy and mastectomy. She said we‘d take the
lump out or take the breast off. I said I did not see a need to remove my breast. I
saw picture of cancer and bottom line the choice was mine. The doctor did not
persuade me.
Sofia: No. I did not question doctor recommendation.
Amy: No. I thought having the cancer mean I was going to die. The doctor say no
previous history in my family of breast cancer.
Beverly: No.
Kim: No. This doctor did not explain much. I was alone. He was not a good
doctor and I could not understand him much from his accent. He said I should
read website information.
Jawanda: Nope the doctor did not encourage me to speak, but something did not
feel right in my spirit that the mammogram was good. I got a second opinion.
Then a second doctor confirmed through biopsy that I have breast cancer.
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Research Question 2
Research question two explored facilitators for post cancer treatment, such as
access to achieving quality cancer care and supportive networks that improve quality of
life for Baby Boomer minority cancer survivors as well as barriers to such quality of life.
Five themes emerged from in-depth interviews from the second research question.
Theme 5
Influence of Social Networks. This theme includes influence of family or
significant persons on their cancer treatment decision. Study participants voiced the
significance of having strong support systems:
Helen: Strong support from sisters and children shared in the treatment decision
and the surgery. It was important to deal with it and move on with or without
family involvement. There was no need to put the surgery off any longer.
Jawanda: My siblings and children were a strong support system.
John: My beautiful wife was on significant in treating all my cancers. A good of
friends and colleagues as well.
Sofia: Yes. Although husband not very talkative. Family member encourage me
to make my own decision. They did not try to talk me out of doing the breast
reconstruction.
Amy: No one encouraged me. I pretty much kept it quite to myself. I did share the
breast cancer with my children.
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Faye: No other family members or friends influenced my decision of breast
surgery or cancer treatment decision. I think family members should be
supportive of the cancer treatment decision.
Participants also responded to a follow up question if a family member or significant
person communicate with their doctor about their cancer treatment option:
Helen: Daughter was there every step of the way, communicated with doctor, and
shared information about my treatment to other family members. My daughter
was there to ask questions and make notes for other family members.
Kim: My husband was supportive and spoke with doctor in a way he could
understand. My mother also spoke with doctors and they were supportive.
Amy: My daughter spoke to doctor on my behalf and getting as much information
to explain to me. It helped me understand the procedures of making the cancer
decision.
Sofia: My daughter talk to cancer doctor but she was in another state. The doctor
was very quiet. Sometimes, I wish I asked more things. I just did not know what
to expect. Someone gave book to read about breast cancer but I was afraid to read
about the breast cancer. It is like, you want to know, but then you do not want to
know.
Faye: I was alone in the decision-making process. No children or other family
members.
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Theme 6
Cancer knowledge. This theme highlighted the participants’ perception of the
incidence of cancer and risk factors for aging.
Kim: No. I was shocked and felt I was much too young to have cancer. I know
that I should receive cancer treatment or I die. I went with the doctors’
recommendation.
Mateo: No. I was 65 when the cancer came.
Amy: No. I was over 50 years old with a teenage son. I want live as long as I
could. I never thought I would get cancer - maybe something else!
Beverly: Nope. I had an emergency the cancer came so late.
Helen: No. I did not think I would get the cancer at this age. However, the doctor
said older women do better with chemo treatments than the younger women do. I
have been relatively healthy and amazed I lived this long without having any type
of surgery.
John: Not really. My first type cancer I was 51 and with cancer again I am 62.
Sofia: No. I did not think that at my 68 age I wanted to go through the breast
cancer. If I were younger, I would not do it. It was too painful! It was hard. The
women in the cancer support group had the breast reconstruction. Some were
happy, but I learned every woman is different.
Faye: No. I was 62 at the time of the breast surgery.
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Theme 7
Financial burden. This theme included the study participants financial resources
affected their cancer treatment decision making such as their health insurance status,
incurred any out of pocket costs as a barrier to pay for their cancer treatment and follow
up care. Participants echoed concerns over cancer cost:
Amy: I had health insurance, but it was not enough. It was not a good plan. I had a
health savings. I had to pay for my mammogram from the health savings. The
other x-rays were included in balance on hospital and doctor bill and making
payment arrangements or $3000.00 or more for the out of pocket costs. I paid copays for the follow up treatment visits.
Beverly: I had little insurance and I was eligible for Medicaid treatment that
covered the surgery so had $0 to pay out of pocket.
Helen: I had Medicare and a Medicare Supplement insurance plan with high
deductible option. My only payment has been for prescription drug co-pays. I did
look at the bills for the procedures and saw the statements were over $5,000 per
visit. It is expensive! I have had no other co-pays on x-rays, or chemo-treatment. I
am blessed!
John: I pay for two insurances Medicare and Tri-Care. It easy to pay for two
insurance than have out of pocket treatment cost. Medicare is the primary
insurance and Tricare is secondary. I was in an HMO with the first cancer. I had
to choose the available doctors within the HMO pool so I could get the greatest
and latest treatment. The first cancer I was thousands of dollars in debt in cost
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sharing. The second cancer with Tri-care only with my total out of pocket was
about $500. The third cancer and treatment, Medicare and Tri-Care both paid for
the radiation treatment. Between these I am current out of pocket cost is $15 per
treatment co-pay and transportation to the treatment center.
Kim: My financial situation was important. I had no insurance. I received a
positive diagnosis with breast cancer at health clinic that does free mammograms
for women from the state. Medicaid funds paid for my breast cancer treatment. I
paid no other out of pocket cost.
Sofia: My husband had health insurance at the time of surgery, but we pay a lot
out of pocket. In the beginning, there were so many tests for me. It was very
expensive. Each time I visit the doctor, I would have to pay $250-300 dollars to
prepay – cash or charge! I had lot of bills after the surgery, almost $2000 my
husband put on the credit card and we tried to pay off the hospital as quick as
possible.
Faye: I had the insurance plan. I paid the 20% co-pay of the charges they sent me
bills and I paid them. Later on, I had forgotten I had purchased a cancer
supplement policy and it that paid me directly. I still have the cancer supplement
plan just in case of a recurring cancer.
Theme 8
Spirituality. This theme included faith, beliefs in a higher power. Participants
expressed their beliefs to ease hem through the cancer treatment process:
Amy: I prayed about the cancer. Through prayer and meditation.
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Kim: Yes. I am a woman of God. I prayed for healing and asked why this
happened to me. It is not cancer that kills; its treatment procedures that reduce the
risk of dying.
Helen: Through my strong faith, I have not suffered, amazing treatment process,
and great doctors. I have faith in God and a good attitude helps! I had no reason to
be sad about the cancer. God takes care of me.
Jawanda: Yes, just simple prayer.
John: Having faith, a strong supportive family. If you do not have a strong
support group its difficult with not one or three cancers. Co-workers put me on a
prayer list that went around the world. The prostate survivors group and great
doctors.
Sofia: Prayer was the only thing that kept me strong. I used to cry a lot. I no cry
much now. I keep talking about it. It gets better after two years. The radiation
make me so tired. The people at senior connections and Latin community support
group were great. I do things now that bring me peace.
Faye: I just prayed for healing through the entire procedure.
Cho: I give thanks to Allah.
Theme 9
Quality of cancer care. This theme reflects on what the medical or cancer team
and to improve quality of cancer. Participants identified their perception of quality of care
in communication with providers and follow-up cancer care treatment:
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Amy: I think my quality of cancer treatment was poor. I was supposed to have a
person from American Cancer Society to visit for support group and counseling
but they never followed up with me about where to get the prosthesis bra.
John: My cancer care team was great supportive group. I felt the cancer team on
the last two cancers were competent. I am better informed about cancer.
Helen: My quality of cancer care was excellent. The cancer surgical staff and
radiation clinic was on point. They told me to call any time.
Kim: The cancer doctor was bad. I have had good doctors and bad doctors. The
most important thing communication is good to discuss with a patient face to face
and not give them a website you do not understand. I wish I had spoken with
another cancer doctor to understand the process better. I did not have enough
insurance in the beginning.
Mateo: Excellent care team communicate all phases to understand.
Sofia: I think I had great cancer care from the doctors and oncologist, and cancer
team. It was good having the doctor speak Spanish and from my same country to
make the journey easy for me.
Faye: I think I got the best cancer treatment. It was good to have the primary care
and oncologist doctors who really cared for me personally. Working as a nurse, I
knew which doctors and hospital were the best to choose from around here.
As a follow up question, study participants shared additional information regarding their
cancer care treatment experiences:
John: Wish I knew more about the insurance process in the beginning.
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Cho: I never got the cancer screening years ago and now it is seem too late for
me.
Helen: My experience with diagnosis to the chemo treatments was good. I was on
a new cancer treatment but my body rejected the initial treatment. I reduce the
stress and worry. I am going on year 3 surviving the cancer.
Jawanda: Some people do not like to talk about their cancer, but they should stay
active if they can.
Kim: The doctor gave me information to make the treatment decision. It was all
up to me. I am thankful to have endured this process. I am feeling better and
increasing my weight and my hair growing back. Looking at minorities for cancer
is important.
Sofia: I feel fortunate that the doctors found the cancer early enough when I came
from my country time enough for cancer diagnosis to treat me. I was crying to
doctors and they say not to cry because I am still alive. I am much better and
happy now. It is a new day for me.
Faye: I thought my cancer experience was a spiritual journey despite the chemo
and radiation. It just made me a better person to help someone else on the journey.
Mateo: Nothing else to say.
Quality of Study
In an effort for this study to be credible in areas of cancer health disparities
among aging minorities is dependent upon quality of data and research findings. The goal
of this phenomenological study focuses on lived experiences of cancer patients through a
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myriad challenges present in a healthcare system is critical to understanding timely and
accurate communications to have better inform decision making for effective cancer
treatment. To ensure the study meets the essential criteria of trustworthiness in this
qualitative research study was credible, confirmable, and dependable to gather the data
collection from participants (Guba and Lincoln, 2007).
1. Credibility – confidence in truth of findings using data triangulation using
multiple data sources to increase and understanding of the study. The study
participants were recruited from more than one community partner to share
their various perspectives.
2. Confirmability – ensure the transcripts from participants were verbatim of
each respective interview. In addition, notes were taken during the interview
process to gather richness of data collection.
3. Dependability – this process was done while simultaneously listening to the
audio-recorded interviews provided by the participants to identify their
experiences relative to the study for feedback to review.
Summary
The purpose of the study was to understand the personal experiences of aging
minorities during cancer treatment decision making when communicating with their
cancer care providers in an urban area of North Georgia. Chapter 4 describes processes of
collecting and analyzing data from the minority cancer survivors regarding their
perceptions of patient and provider communication during the cancer treatment decision
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making. Purposeful sampling was done to study this phenomenon. Participant responses
from in-depth interviews ask specific questions from the interview guide.
The first research question explored the participants’ experience with cancer
treatment decision making and patient-provider communication. The majority of the
participants seemed satisfied with the patient-provider communication and access to
cancer care treatment they received. However, a couple of participants felt provider
communication was inadequate about their cancer treatment. The second research
question looked at the importance of spiritual and social networks and barriers to access
to quality cancer care. Many participants felt they received good quality of cancer care.
Family, friends, and faith was significant to the participants. Chapter 5 will further
address the interpretation of the cancer study findings, limitations of the study, and
conclusions, social change implications, and researcher’s recommendations to increase
quality cancer care for surviving aging minority populations.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to examine the personal experiences of aging
minorities during cancer treatment decision making when communicating with their
cancer care providers. Multiple studies identified the significance of quality patient and
provider communication between older individuals with cancer and their care provider.
The literature is limited on studies that focus on specific experiences with cancer decision
making and communication with providers for this population.
I conducted a phenomenological research approach with in-depth face-to-face
interviews among 10 individuals about their cancer experiences when communicating
with their cancer care providers. Phenomenological research focuses on the participants’
worldview of experiences to understand a phenomenon under investigation (Creswell,
1994). The investigator relies on the richness of descriptive in-depth interviews to
understand their experiences, and then analyzes the data to generate common themes
from the phenomenon.
I identified the cancer treatment decision-making experiences of 10 individuals
born between 1945 and 1964. In this chapter, I discuss an interpretation of the findings
based on the research questions and themes related to cancer treatment decision-making
as identified from participant data. I also provide the conceptual framework, limitations
of the study, recommendations for future research, social change implications, and
summary.
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Interpretation of the Findings
Study participants shared brief personal demographic information including age,
gender, race, income; marital status, educational level, and health insurance status (see
Table 3 in Chapter 4). Participants included a total of 10 women and men who were at
least 2 years post diagnosis. The majority of the participants were retired. The average
participant was 64.3 years of age. The number of cancer survivors age 65 and older is
projected to rise in part due to aging population trends, changing demographics, and
improvements in cancer care (Bluethmann, Mariotto, & Rowland, 2016; White, Hayes, &
Richardson, 2015).
Most participants reported having surgery and chemotherapy as primary
treatments for their specific cancer type (see Table 6, Chapter 4). Many participants
reported late stage of their cancers at diagnosis. Although this study did access late stage
cancers, the current research indicates some late stages of cancer are highly associated
with an increased risk of cancer death (Richardson, Tai, Rim, Joseph, Plescia, 2011;
Henley et al., 2010). In addition, late stage cancers may be associated with fear, distress,
and limited understanding of cancer treatment options (Schubart, Farnan, & Kass (2015).
Screening cancer among specific demographic groups warrants early diagnosis of cancers
(Wu, et al., 2015). Mobley and Kuo (2017) found that race or ethnicity for breast and
colorectal cancer among African Americans, Hispanics, and Asians are more likely to
receive late stage at diagnosis than Whites in most states are.
Cancer survivors comprise multiple racial ethnic backgrounds with various cancer
types and other comorbidities (Bluethmann et al., 2016). In the United States, breast
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cancer is the most common cancer in women and CRC is the most common cancer in
men (ACS, 2015, 2016). Despite progress in cancer care, disadvantaged populations are
impacted by cancer health disparities, particularly racial and ethnic minorities, and the
poor are disproportionately burdened by cancer (Smith & Hall, 2015; Zonderman et al.,
2014). Multiple studies indicate African Americans have the highest incidence of and
death rates from cancer compared to other racial and ethnic minorities (NCI, 2018; ACS,
2014; Maly, Umezawa, Ratliff, & Leak, 2011). According to Hummer & Gutin (2018),
understanding the context of racial and ethnic health disparities, institutional and
individual racism, lack of access to health care, and poor access to quality education and
employment is necessary to interpret prevalence and mortality of all cancers among racial
and ethnic minorities.
Research Question 1
RQ1: Do inadequate time allowed for medical decision-making and lack of active
listening and empathy by care providers prove to be barriers to patient-provider
communication for minority Baby Boomers?
The interview questions revealed that interpersonal relationships could affect the
outcome of quality of patient provider communication and influence cancer treatment
decision making among Baby Boomers. Having good social support structures with a
family member or friend as a facilitator is valuable for good cancer treatment decision
making. The barriers to good decision-making identified in this current study were
patient-provider miscommunication, needing more time with the doctor, and mistrust of
the medical profession. This finding is consistent with Mead et al (2013) that patients
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want more communication that is informative to guide their decisions for cancer
treatment after the cancer diagnosis.
Theme 1: Cancer diagnosis. The study participants conveyed being
overwhelmed with receiving the cancer diagnosis news after communicating with their
providers during a follow up visit. The need for education of cancer prevention is critical
for the older minority populations. All participants found out they were diagnosed with
cancer during a follow-up examination the doctors’ recommendation of other diagnostic
testing to confirm the cancer diagnosis. One participant reported been diagnosed for
cancer three times. Although this study does not assess screening adherence, this is a
critical finding that is consistent with the current literature that having a medical
provider’s recommendation is a strong indicator of patients completing and getting
screened for cancer for breast, cervical, prostate, and colorectal to find cancers early
when they may be treatable or curable (CDC, 2018).
Theme 2: Understanding and response. This theme identified barriers to
empathy, time listening, understanding, and response of participants when facing a
complex decision. The study participants (n= 7) perceived poor interpersonal
communication as a lack of understanding cancer treatment decision making when
discussing cancer treatment options with their providers, along with other unmet
information needs. Communication of empathy, caring, respect, and imparting sensitivity
to the patient’s health literacy is important for patients’ ability to understand health
information for adequate treatment decision making for cancer (CDC, 2016). Good
cancer communication helps patients understand to the best of their ability (Ko et al.,
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2016; Manfredi, Kaiser, Matthes, & Johnson; 2010). For example, participants did not
understand chemotherapy versus radiation therapy or other effective treatment options for
their type of cancer. This finding is consistent with the finding that shared
communication, patient-centered care, and patient-provider communication is essential
for all individuals with cancer and helps patients to receive bad news, deal with the
emotional impact of cancer, understand complex information, and handle dealing with
multiple health professionals (CDC, 2016; Song, Hamilton., & Moore, 2012; Epstein &
Street, 2011). Limited health literacy contributes to health disparities and is a critical
barrier to quality cancer communication and completion of doctors’ recommendations for
routine screenings and treatment (NCI, 2018).
Theme 3: Provider information giving. In the current study, three out 10
participants indicated the providers did not encourage them to ask important questions
about their treatment options. One participant, a nurse, was satisfied with her doctor’s
suggestion to write down all her questions about the breast cancer surgery before the next
appointment. According to Song et al. (2012), patients not knowing specific questions to
ask the provider are limited in cancer treatment discussions, which translates into lack of
communication. Sofia said,
The doctor did not discuss much. In addition, I did not know what to ask the
cancer doctor. I just trusted everything the doctor said. He was Hispanic and
speaks Spanish like me. It was easy for me to communicate with him, easy to trust
and to communicate. He never told me we have this option or that. I told him to
do what needed to be done.”
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This finding is consistent with research by Heiney, Messias, Felder, Phelps, & Quinn
(2017) that concluded women trusted their providers’ recommendation “just do it” and
noted that trust may enhance adherence to breast cancer treatment. In contrast, findings
from Ching-Li, Matthews, Dossaji, & Fullam (2017) examined patient-provider
communication variables and concluded the majority of participants reported satisfaction
with provider communication, were comfortable asking questions about their cancer
diagnosis and treatment and with physicians discussing cancer diagnosis and treatment
options with them.
Theme 4: Engaged patients. All study participants were unaware they had a
voice in deciding their cancer care. The majority of the participants (n = 9) did not seek
another surgical opinion to validate the initial recommendation but followed the doctors’
recommendations. For example, one participant, stated, “The doctor communicate he was
99/100% sure that everything is ok with me. I didn’t feel comfortable about the
mammogram being good so I got a second opinion.” The second doctor confirmed
through biopsy that cancer was present. This finding is consistent with patients talking
openly regarding their concerns and fears with cancer treatment options (Epstein &
Street, 2011). The lack of communication leads to medical mistrust in the health
institutions, dishonesty about the diagnosis and treatment recommendation, and
discrimination, which results in underutilization of health services (Song et al., 2012;
LaVeist & Williams, 2009).
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Research Question 2
What are facilitators for post-cancer treatment (e.g., access to quality care and
supportive networks) that improve quality of life of Baby Boomer minority cancer
survivors? What are the barriers to improved quality of life?
Theme 5: Influence of social networks. All study participants indicated the
strongest influence on their treatment decisions and follow up care was the loving support
of family, friends, and higher power other than themselves. Family, friends, and or
spiritual networks are essential for helping patients cope with cancer and promote healing
during cancer treatment. This is consistent with findings from several studies that found
social networks are effective to meet needs associated with improved survival of cancer
(Yoo et al., 2010; Goodwin, 2007; Kroenke et al., 2006). Yoo et al. (2010) examined 47
older African American, Asian, Caucasian, and Latino women from various ethnically
diverse populations and concluded women with strong informal support from family and
friends are more likely to have higher quality interactions with medical professionals.
Supportive networks also include collaboration of community partnerships to address
cancer disparities among racial ethnic minorities to increase health outcomes (Molina,
McKell, & Mendoza, 2016; Ramandhan et al., 2012).
Theme 6: Cancer knowledge. Participant perception was limited about cancer
knowledge, risk factors, and increases of cancer, as a person gets older. This finding
highlights the need for communicating cancer prevention, screening, detection, and
treatment information critical for aging and racial ethnicities. In the United States, about
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350,000 individuals diagnosed with breast, cervical, or colorectal cancer, and nearly
100,000 die yearly from these diseases (CDC, 2012).
Theme 7: Financial burden. Accessing high quality cancer care depends on
ensuring aging minority Baby Boomers receive timely access to cancer treatment. The
study identified barriers such as health care systems factors, transportation, provider
communication, cultural, or out-of-pocket cost may impacts access to cancer care.
Participants (n=2) reported a health systems barriers with long wait-times at public or
teaching health systems for follow up cancer care. All participants reported having health
insurance coverage to access their cancer care treatment. The health insurance status
reported by participants varied, with Tricare/Veterans Administration (n=1), Medicare
(n=4), Medicaid (n=2), private employer insurance (n=4). Two participants had medical
insurance but reported being under-insured for cancer treatment. These participants were
still able to receive cancer treatment services through other public or community services
with no out of pocket cost. Another participant had dual insurance coverage. Multiple
studies indicate that having access to health insurance is the most important indicator in
determining receipt of timely access to cancer treatment (Walker et al., 2014; Halpern,
2008).
For the current study, out of pocket, participants when facing cost of treatment for
co-insurance, high deductibles and premiums, and medication incurred cost. This is
consistent with the current study on two insured participants several months paying for
out of pocket cost to cover coinsurance, deductibles, and prescription drugs. Amy
describes her out pocket experience: “I had to make payment arrangements or $3000.00
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or more for the out of pocket costs. I paid co-pays for the follow up treatment visits.”
Three participants in the current study, over aged 65 insured under Medicare, indicated
additional supplement plan coverage to helped pay for Medicare deductibles and
coinsurance amounts reported substantially less out of pocket cost for cancer treatment.
For example, Helen said, “I had Medicare and a Medicare Supplement insurance plan
with the high deductible option. My only out-of-pocket payment has been prescription
drug co-pays. I have not had other co-pays on x-rays, or chemo-treatment. I’m blessed!”
The impact of financial difficulties on patients with cancer are becoming well
recognized with financial distress can associated with physical, social, and emotional
functioning reported (Delgado-Guay et al., 2015). Findings from a research study on the
impact of health care costs on well-being and treatment among cancer patients, suggest
that insured patients undergoing cancer treatment experience substantial financial burden,
and that having health insurance coverage does not eliminate financial distress
experienced by many cancer patients (Zafar et al., 2013).
Income inequality and unemployment include disparities in access to health care
and usually also associated with disproportionately lower cancer survival rates among
many aging minorities (Abdelsattar et al., 2016). The Patient Protection and Affordable
Care Act (ACA) extends Medicaid coverage to many cancer survivors who were unable
to purchase affordable health insurance coverage in the individual Health Insurance
Exchange Marketplace (ACA, 2010). The ACA expands access to care, largely through
the Medicaid expansion, to individuals with 138% of those incomes near the national
poverty levels (Nikpay et al., 2018; Rudowitz, 2014).
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The Federal Government supports free or low cost breast and cervical cancer
screening services across the United States to women who cannot afford cancer-screening
services. This was important for helping Kim access cancer treatment care: “I had no
insurance and was diagnosed with breast cancer at health clinic that does free
mammograms for women from the state. Medicaid funds paid for my breast cancer
treatment. I paid no other out-of-pocket cost.” Women diagnosed with cancer after
receipt of breast or cervical cancer services through the National Breast Cervical Cancer
Early Detection Program (NBCCEDP) are eligible for Medicaid coverage gain access to
timely cancer treatment through the Breast and Cervical Cancer Prevention and
Treatment Act of 2000, Public Law 106-354 (CDC, 2018). The law also extends
coverage to American Indians and Alaska Natives who are eligible for health services
provided by the Indian Health Service or by a tribal organization under the passage of the
Native American Breast and Cervical Cancer Treatment Technical Amendment Act of
2001 (CDC, 2018).
Cancer costs are enormous. Estimates of the direct medical costs (total of all
health care costs) for cancer in the United States in 2015 were $80.2 billion; with 52% for
outpatient and physician office visits and 38% for inpatient hospital visits (ACS, 2018). In
2018, about 609,640 Americans expected to die of cancer (ACS, 2016). These deaths
include uninsured and ethnic minority groups diagnosed with cancer at a later stage,
when treatment is more extensive, costlier, and less successful (ACS, 2018). The
implementation of the Affordable Care Act (ACA) helps to alleviate some of the burden
of cancer for patients and families. For example, the ACA prevents health insurers from
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excluding coverage based on preexisting conditions, including cancer (ACA, 2010).
Financial problems caused by cancer impact on quality of life (Fenn et al., 2014). It is
important to provide people with information on cancer to understand their health
coverage, seek financial assistance programs.
Theme 8: Spirituality. For study participants, the relationship between family
members, friends have a strong influence on cancer treatment decision making. All
participants discussed prayer, faith, family, and giving all blessings to God for bringing
them through the cancer experience. This finding is consistent with Sterba, Burris,
Heiney, et al. (2014) on religiousness and spirituality are essential to survivorship, and
care giving following primary cancer treatment and racial and ethnic minorities more
likely to rely on religious and spiritual faith to cope with emotional support.
Theme 9: Quality of Cancer Care. The majority of the study participants
reported receiving good access and quality care in communication with provider about
cancer treatment decision making. The participants verbalized that the importance of
good interpersonal communication with provider as opposed a website or information
pamphlet to learn about their cancer. Other participant factors include not knowing more
about the insurance process, and getting a cancer screening years earlier when the cancer
is detected and most treatable. These findings highlight the need for interventions aimed
at insuring that patients and families are educated and empowered during the cancer care
continuum. When patients are less empowered, during and after the cancer, treatment
process can lead to poor health outcomes and reduce the quality of cancer care, and
increase survival rates. (Cancer Support Community, 2016). Despite advances in
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technology, underserved populations suffer from disparities in cancer treatment outcomes
for rural populations, and the elderly. Patient decision making may be influenced by
attitudes and beliefs about specific treatments, life circumstances and competing
demands, health literacy, and perceptions about the health care system (Frey et al., 2016).
When patients are less empowered, during and after the cancer treatment process can lead
to poor health outcomes, reduce the quality of cancer care, and increased survival rates.
These findings suggest that engaged patients is a central goal for individuals living with
cancer during the shared decision-making process.
Conceptual Framework
The SEM was the framework to develop my research agenda, data analysis and
summary. The findings from this study focused on timely access to cancer treatment
services influenced by the intrapersonal, interpersonal, community, organizational, and
public policy.
The organizational level of SEM has a strong influence on patient-provider
communication, cultural competency, and health literacy for cancer prevention for racial
and ethnic minorities. For example, the organizational level of SEM is where individuals
or patients have access to providers for cancer services. First, having a medical home for
patients so that providers can communicate a recommendation or reminder for screening,
and follow-up for patients’ access to cancer care. Stigma or fear of having received a
diagnosis for cancer, financial burden, and or transportation to the treatment facility are
access barriers. The organizational level of SEM also influences effective interventions to
address cancer health disparities through collaborative approaches for cancer to engage
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patients, individual providers and health systems, academia, faith based organizations,
media, and state health departments at work to reduce burden of cancer and improve the
quality of life for cancer survivors. The policy level also addresses improvements in the
overall health of cancer survivors Healthy People 2020 and the Affordable Care Act
(ACA) expands insurance reforms and improve access to cancer care with specific
measures to eliminate barriers to reduce cancer health disparities among aging minorities.
Limitations of the Study
This study had some important limitations including the small sample size,
geographic location, and potential for bias. The study was limited to a sample of 10
participants. The limited sample size may not accurately represent the perception of
patient-provider communication among aging minority patients when discussing cancer
treatment. The study was limited to an urban area of North Georgia; therefore, the study
findings may not reflect the experiences of racial and ethnic minority Baby Boomers
outside the study area. Additionally, the study did not account for cancer treatment side
effects, biology of cancer, palliative or hospice care communications or other chronic
conditions that advance cancer. The study did not collect data from health care providers
who are critical to achieving effective communication for aging minorities. The data was
reported by study participants, therefore, there is a potential for recall bias. Another
limitation is that only two community organization partners agreed to participate in the
study that limited the ability to recruit a diverse sample of racial and ethnic minorities.
The majority of the study participants were African American, an ethnic group that is
often under-represented in clinical studies. Despite these limitations, these participants
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have conveyed a unique perception of their cancer treatment decision-making
experiences. This study may affect future outcomes research needs for aging racial and
ethnic minorities.
Recommendations
This study looked at patient-provider communication to reduce cancer among
aging racial and ethnic minority populations at high risk for cancer in the United States.
The findings of this study contribute to the existing literature of minority Baby Boomers
perception of patient and provider communication when making cancer treatment
decisions. To reach this aging minority population health care providers should
strengthen shared communication and decision-making strategies to improve quality and
reduce cancer health disparities.
Another recommendation is increase education among the growing aging
populations about access barriers to health insurance to increase their understanding of
cancer care and patient cost of cancer treatments. Engaging patients with cancer and their
families with communities strengthens support networks and increases the quality of life
for cancer survivors. The literature is scant on patient perception of cancer among aging
minority populations in community settings. A specific recommendation is for the
inclusion of older racial ethnic populations in research interventions to better understand
and respond to the needs of this population when communicating with providers about
cancer treatment decision-making. For example, some older cancer patients may distrust
the healthcare system, or providers who deliver inadequate or inequitable communication
during the decision-making process. Having culturally tailored decision-making tools
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with representatives of older individuals of color may make it more accessible to address
communication gaps during the cancer treatment decision-making experience. Materials
can be translated into various languages to convey culturally appropriate messaging to
make it easier for patients and providers to understand the shared decision making.
Finally, the recruitment of older minority participation into aging research studies needs
to evaluate effective interventions for specific populations living with cancer.
Implications for Social Change
The findings from this study has the potential to affect social change for
underserved men and women aging populations. The findings may contribute to body of
knowledge about the lived experiences of racial and ethnic minorities regarding cancer
interventions to improve patient-provider communications among aging Baby Boomers.
In addition, the study may lead to future research to identify important factors to advance
the field of cancer epidemiology. Additionally, the findings have the capability to inform
public health approaches that correlate to poor health outcomes for cancer diagnosis and
treatment relevance to minority aging and health disparities in the United States. The
results of the study suggest a need to bring awareness to community-based organizations
serving aging minorities and may reduce access barriers to cancer treatment when faced
by cancer survivors.
Summary
In conclusion, based on data analysis from this qualitative, phenomenological
study incorporated in-depth interviews with 10 cancer patients currently in treatment.
Often when adult patients confronted with a cancer diagnosis, the health care
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professionals must be accountable to needs of the individuals during the transition from
diagnosis to treatment decision making. The findings from this study may add to limited
knowledge on cancer treatment decision making in aging racial ethnic minorities can
improve cancer disparities and health equity among vulnerable populations.
Research Question 1 explored the participants’ experience with cancer treatment
decision making with patient-provider communication. It was determined, that
communication is essential to trust between the patients and providers to help cancer
patient understand complex information, cope with uncertainty and emotional impact of
the cancer experience, and make appropriate and timely cancer treatment decisions.
Significant findings identified barriers related to the provider’s miscommunication,
needing more time with the cancer doctor, and mistrust of the medical professor. Poor
interpersonal communication as a lack of understanding cancer treatment decision
making when discussing cancer treatment options with their providers.
Research Question 2 explored facilitators for post cancer treatment, the
importance of spiritual and social networks and barriers accessing quality cancer care. All
participants indicated the strongest influence on their cancer treatment decisions and
follow up care was the loving support of family, friends, faith in God, and prayer. These
are all essential for helping cancer survivors cope with cancer. Additionally, the financial
burden for underinsured participants through out of pocket cost to cover coinsurance,
deductibles, and prescription drugs for cancer treatment impacts quality of life. Reducing
long wait-times at public or teaching health systems is a barrier when navigating follow
up cancer care services.
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Lastly, Chapter 5 discussed the conceptual framework of the study based on the
Social Ecological Model (SEM) focused on multi-level approaches of patient-provider
communication from a public health perspective. The recommendations and findings of
this study may contribute to the existing literature of minority Baby Boomers perception
of patient-provider communication when making cancer treatment decisions. To reach
the aging minority population health care providers should strengthen access and improve
communication strategies may reduce mortality and morbidity of certain cancers.
Additionally, the results of the study may bring awareness to care givers and cancer
survivors among area aging organizations servicing racial ethnic minorities.
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Appendix A: Letter of Cooperation
Letter of Cooperation from (Insert Community Health Center Partner)

Community Health Center
Address
Date
Dear Patrice L. Kemp,
Based on my review of your research proposal, I give permission for you to conduct the
study entitled Cancer Treatment Decision Making in Aging Minorities within the
(Community Health Center). As part of this study, I authorize you to conduct up to 15
semi-structured in-depth interviews with individuals born between 1946 and 1964,
diagnosed with a cancer such as breast, cervical, colorectal, prostate or other diagnosed
form of cancer. Proper names will not be used and participants will be assigned a
pseudonym to protect their identity. Interviews can last up to 1 hour. Individuals’
participation will be voluntary and at their own discretion.
To ensure validity, Ms. Kemp may audio record the interview of consent form study
participants. A structured interview note taking for consistency with study participants
will follow all interviews. If requested, (Community Health Center) will receive an
electronic copy of the study.
We understand that our organization’s responsibilities include permission to interact with
participants for completing this research. We reserve the right to withdraw from the study
at any time if our circumstances change.
I confirm that I am authorized to approve research in this setting and that this plan
complies with the organization’s policies.
I understand that the data collected will remain entirely confidential and may not be
provided to anyone outside of the student’s supervising faculty/staff without permission
from the Walden University IRB.
Sincerely,
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Authorization Official
Contact Information
Walden University policy on electronic signatures: An electronic signature is just as valid as
a written signature as long as both parties have agreed to conduct the transaction
electronically. The Uniform Electronic Transactions Act regulates electronic signatures.
Electronic signatures are only valid when the signer is either (a) the sender of the email, or
(b) copied on the email containing the signed document. Legally an "electronic signature"
can be the person’s typed name, their email address, or any other identifying marker. Walden
University staff verify any electronic signatures that do not originate from a passwordprotected source (i.e., an email address officially on file with Walden).
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Appendix B: Interview Guide

Personal Interview Guide
Cancer Treatment Decision Making in Aging Minorities
Code ID #: ___________
Date: _______________

Place/Time of Interview:

______________
Participant Sociodemographic
1. Age: ____
2. Gender:
Male ____

Female ____

3. Race/Ethnicity:
Asian ___ Black or African American ___ Indian/Alaska Native___
Hispanic/Latino ___ Hawaiian or Pacific Islander ___White ___ Other __
4. Marital Status:
Single ____ Divorced ____ Married____ Widowed ____
5. Educational level:
Less than high school
High school/GED
Some college
College graduate

_____
_____
_____
_____

6. Income:
Below - $25,000
$25,000 - $35,000
$35,000 - $50,000
$50,000 - $75,000
Above - $75,000

_____
_____
_____
_____
_____
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7. Health insurance status:
Campus/Tricare/VA _____
Indian Health Service _____
Medicare
_____
Medicaid
_____
Private / Employer _____
Self-Pay
_____
Other
_____
No insurance
_____
8. Type of cancer:
Breast
Prostate
Colon/rectal
Cervical/Ovarian
Leukemia
Lung
Other

_____
_____
_____
_____
_____
_____
_____

9. Stage of cancer at diagnosis:
Stage I
_____
Stage II
_____
Stage III or IV
_____
10. Type of Cancer treatment:
Surgery
_____
Chemotherapy
_____
Radiation
_____
Hormone therapy
_____
Immune therapy
_____
11. Length of time (years) with cancer treatment provider:
<2
_____
3-4
_____
>5
_____
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12. Other medical condition(s):
_________________________________________________

Interview Questions
1. Describe how you first learned about your cancer diagnosis?

2. Describe how your cancer doctor discussed treatment options you
can understand in making decisions about your cancer treatment
process?

3. Please tell me how long was your cancer treatment decision made
after the cancer diagnosis?

4. Please describe how your cancer doctor encouraged your
involvement to ask important questions about your cancer
treatment options?
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5. Did your doctor encourage you to voice your opinion (agree or
disagree) about your cancer decision test or specific treatment
recommendation?

6. Please describe how family members or significant individual(s)
influenced your cancer treatment decision.

7. What ways have the family member or significant individual(s)
communicated with your doctor about your cancer treatment
options?

8. In what ways do you feel your age plays a role in your cancer
treatment decision making?

9. In what ways do you feel your financial resources play a role in
your cancer treatment decision making?
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10.Did your spiritual beliefs and religion engagement influence your
cancer treatment decisions? If so, explain how you dealt with this
serious physical illness?

11.In looking back, what things do you think the medical care team
can do to improve quality cancer care with patients?

12.Are there any additional comments you would like to provide
about your cancer treatment decision experiences?

Thank you for participating in this interview. The confidentiality of all
responses will be maintained.
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